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 Development of the adult form requires coordinated growth and patterning of 
multiple traits in response to local gene activity as well as global endocrine and 
physiological effectors. In recent years the zebrafish has been utilized as a favorable 
animal model as a step towards dissecting and better understanding these postembryonic 
developmental processes. One of the more powerful methods utilized in zebrafish has 
been the identification of new gene functions through the use of mutant screens. The 
nutria mutant was recovered from one such screen to identify postembryonic defects in 
pigment pattern, growth and metamorphosis. These mutants exhibited a pigment cell 
defect, touch unresponsiveness and severe growth retardation. Here I will discuss my 
work towards dissecting the underlying developmental processes governing the 
phenotypic changes in nutria mutants. I characterize gross alterations in skeletal 
development in nutria mutants that lead to accelerated endochondral ossification but 
delayed intramembranous ossification. I show that the nutria phenotype results from 
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mutations in trpm7, which encodes a transient receptor potential (TRP) family member 
that functions as both a cation channel and a kinase. I find trpm7 expression in the fish-
specific, ion homeostasis-regulating gland known as the corpuscles of Stannius (CS), and 
in the mesonephric kidney. I show that mutants also develop kidney stones. Together 
these results suggest a role for trpm7 activity in regulation of physiological ion 
homeostasis. Next I confirm that role by identifying late-embryonic and early larval 
defects in the CS and the kidney, two organs that regulate physiological ion homeostasis. 
I demonstrate the early larval detection of kidney stones in trpm7 mutants and show that 
their appearance is presaged by decreased levels of total calcium and magnesium. 
Furthermore I establish a link between trpm7 function in the CS and stanniocalcin1 
(stc1), a potent molecular regulator of calcium homeostasis. Finally, using transgenic 
overexpression and morpholino-oligonucleotide knockdown, I demonstrate that stc1 
modulates calcium and magnesium levels in trpm7 mutant and wild-type backgrounds. 
Together these analyses establish postembryonic roles for trpm7 function in growth, 
skeletogenesis, kidney function, and physiological ion homeostasis. 
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Chapter 1: Background  
 
Introduction 
 Much of what makes an organism is circumscribed by its embryonic 
development. Germ layers are defined, cell lineages are determined and tissue 
differentiation occurs. More than a century of effort has gone into dissecting and 
discerning the mechanisms governing these processes. While much of an organism’s 
development is determined during embryonic stages, still more is established during 
postembryonic stages. Many organ systems continue to develop and mature, or only 
become fully functional at postembryonic stages. Furthermore, once many key 
developmental processes have been established their maintenance and regulation 
becomes a vital priority. These processes can often be less well defined than those at 
early embryonic stages.  
 As a step towards dissecting and better understanding postembryonic 
development, the zebrafish has been developed into a favorable animal model for 
studying these processes. Mutant screens were performed to identify postembryonic 
defects in pigment pattern, metamorphosis, and other related processes. From a mutant 
screen to identify postembryonic defects in pigment pattern, growth, and metamorphosis 
we identified the mutant nutria. These mutants exhibited a pigment cell defect, touch 
unresponsiveness and severe growth retardation. In the follow chapters I present my work 
towards understanding the developmental processes at work in zebrafish nutria mutants.  
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 In Chapter 2, I describe the identification of trpm7 as the gene corresponding to 
nutria. TRPM7 is known to be a primary regulator of cellular magnesium homeostasis in 
mammalian systems (Schmitz, Perraud et al. 2003). However work in this chapter will 
show that in zebrafish dysfunctional trpm7 can have broader impacts. I characterize 
postembryonic defects present in zebrafish trpm7 mutants that greatly impact growth, 
skeletogenesis and kidney function. I demonstrate how mutants exhibit a severe growth 
retardation that does not manifest until larval stages. Furthermore, I show that at larval 
stages these mutants also display significant disruption in the sequence and timing of 
ossification between endochondral and intramembranous bones, with premature 
ossification of endochondral bones and delayed ossification of intramembranous bones. 
Finally I identify kidney stone formation within the mesonephric tubules of the larval 
kidney in mutants. This, together with strong trpm7 expression detectable in the larval 
kidney and corpuscles of Stannius, organs responsible for ion homeostasis, suggests a 
role for trpm7 in the physiological regulation of postembryonic growth and 
skeletogenesis. 
 In Chapter 3, I further explore a potential role for trpm7 in governing 
physiological cation homeostasis. I determine that the function of both the kidney and the 
corpuscles of Stannius (CS), two organs impacting physiological ion homeostasis, is 
altered in trpm7 mutants. I demonstrate the presence of kidney stones in mutant larvae 
shortly after hatching and misregulation of a key calcium regulating hormone, 
stanniocalcin1 (stc1), in the CS prior to hatching. I find that decreased total calcium and 
magnesium levels in mutants follows upregulation of stc1 but precedes kidney stone 
 2
formation. Furthermore, using transgenic overexpression and morpholino-oligonucleotide 
knockdown, I demonstrate that stc1 modulates calcium and magnesium levels in trpm7 
mutant and wild-type backgrounds. Together these analyses demonstrate distinct roles for 
trpm7 in regulating cation homeostasis through kidney function and via stc1 expression 
within the CS. 
 In the Appendices, I discuss other experiments aimed at a broader understanding 
of zebrafish trpm7 function. These include establishing zebrafish lines with conditional 
trpm7 function, either through identification of temperature sensitive (TS) mutant alleles, 
or through the establishment of a transgenic line capable of inducing overexpression of a 
dominant-negative form of trpm7 (DN-trpm7) (Appendix I). Additionally, I describe 
experiments to identify differences in water composition between fish facilities at the 
University of Texas and the University of Washington, and how they impact observed 
phenotypes (Appendix II). Other work discussed includes in vivo detection of kidney 
stone formation in heterozygous trpm7 mutants (Appendix III), potential changes in 
phosphate levels in trpm7 mutants (Appendix IV), and how the potential effects of stc1 
overexpression at larval stages may provide an explanation for later stage defects in 
trpm7 mutants (Appendix V). 
 To provide a better context for the rationales behind the following experiments in 
later chapters I briefly review the pertinent topics of bone and kidney development, 
physiological ion homeostasis, and the functions of the broader family of TRP channels, 
of which TRPM7 is a member. Much of this reviews the processes as they occur in 
mammalian systems as a reference point, then discusses how they differ in fish. Since 
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ultimately the purpose of these studies is to use zebrafish as a broader model for 
vertebrate postembryonic development, the review is meant to help put the research into 
this broader context. 
 
Bone Development 
 One of the defining processes of post-embryonic vertebrate development is the 
formation and maintenance of bone. This is the process by which a vertebrate organism 
develops and maintains its skeletal architecture and is governed by a wide range of 
factors controlling patterning, timing, formation, maintenance and resorption of bone. 
Often these factors play additional roles in growth, renal function, mineral homeostasis, 
and metabolism (McCarthy and Centrella 2001; Zhang, Xuan et al. 2002; Olney 2003; 
Schipani and Provot 2003; D'Souza-Li 2006; Kronenberg 2006; Wu, Yoshiko et al. 2006; 
Doyle and Jan de Beur 2008; Egbuna and Brown 2008; Quarles 2008; Datta and Abou-
Samra 2009; Samadfam, Richard et al. 2009; Theman and Collins 2009; Tsagalis, 
Psimenou et al. 2009). There is a complex interplay between these factors in maintaining 
a balance in the regulation of these processes, and disruption of this balance can have 
severe consequences not only in development or maintenance of bone, but also in the 
regulation of other developmental processes such as growth or renal function (Schipani, 
Kruse et al. 1995; Karaplis, He et al. 1998; Kuizon and Salusky 1999; Gonzalez and 
Martin 2001; Kuizon and Salusky 2002; Bajaj and Saag 2003; D'Souza-Li 2006; Egbuna 
and Brown 2008; Sipos, Pietschmann et al. 2009). For example, genetic defects related to 
parathyroid hormone signaling can not only lead to hypo- or hypercalcemia (Schipani, 
 4
Kruse et al. 1995; Karaplis, He et al. 1998; D'Souza-Li 2006; Egbuna and Brown 2008; 
Theman and Collins 2009), but also impact growth and induce precocious maturation of 
bone (Schipani, Kruse et al. 1995; Karaplis, He et al. 1998). 
 Aside from genetic defects, non-genetic factors can also influence the skeleton, 
and lead to diseases such as osteoporosis or renal osteodystrophy (Gonzalez and Martin 
2001; Bajaj and Saag 2003; Sipos, Pietschmann et al. 2009). In osteoporosis, hormonal 
imbalances lead to increased bone resorption and result in delicate or brittle bones. In 
renal osteodystrophy, kidney dysfunction or kidney failure leads to decreased serum 
calcium levels and reduced bone mineralization; the result of which include bone 
deformations and bone fractures. These non-genetic factors may include calcium 
deficiency, vitamin D deficiency, the loss of estrogen associated with menopause, or 
kidney failure (Fujita 2000; Cosman 2005; Gal-Moscovici and Sprague 2007; Bischoff-
Ferrari and Staehelin 2008; Wolff, Jones et al. 2008; Doumouchtsis, Perrea et al. 2009; 
Williams 2009). Understanding the mechanisms and factors governing bone development 
is vital to designing treatments that will combat these defects. 
 Bone development occurs in one of two ways: endochondral bone formation or 
intramembraneous bone formation (de Crombrugghe, Lefebvre et al. 2001; Kronenberg 
2003; Provot and Schipani 2005; Cohen 2006). Endochondral bone is formed through a 
cartilage intermediate while intramembraneous bone is formed without a cartilage 
intermediate (de Crombrugghe, Lefebvre et al. 2001; Kronenberg 2003; Provot and 
Schipani 2005; Cohen 2006). Furthermore, once bone is formed, it is maintained, 
renewed and resorbed through the process of bone remodeling (de Crombrugghe, 
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Lefebvre et al. 2001; Kronenberg 2003; Provot and Schipani 2005; Cohen 2006). The 
mediators of bone formation and bone remodeling are chondrocytes (cartilage-forming 
cells), osteoblasts (bone-forming cells) and osteoclasts (bone-resorbing cells) (de 
Crombrugghe, Lefebvre et al. 2001; Kronenberg 2003; Provot and Schipani 2005; Cohen 
2006).  
 In endochondral bone development, chondrocytes differentiate from 
condensations of mesenchymal precursors and lay down a cartilage matrix on which 
subsequent bone matrix will be added. The differentiation of the chondrocytes is 
primarily controlled by Sox9 (Bell, Leung et al. 1997; Bi, Deng et al. 1999), though Sox5 
and Sox6 also work synergistically to promote early stages of chondrocyte differentiation 
(de Crombrugghe, Lefebvre et al. 2001; Kronenberg 2003; Provot and Schipani 2005; 
Cohen 2006). Chondrocytes lay down a cartilage matrix comprised primarily of collagen 
II, though cartilage matrix is also comprised of proteoglycans such as aggrecan (de 
Crombrugghe, Lefebvre et al. 2001; Kronenberg 2003; Provot and Schipani 2005; Cohen 
2006; Domowicz, Cortes et al. 2009; Gentili and Cancedda 2009). As chondrocytes 
mature, Indian hedgehog (Ihh) works through Parathyroid hormone-related protein 
(PTHrP) signaling to promote chondrocyte proliferation and bring them to the threshold 
of hypertrophy, but then prevents them from crossing that threshold (Chung, Lanske et al. 
1998; de Crombrugghe, Lefebvre et al. 2001; Kronenberg 2003; Amizuka, Davidson et 
al. 2004; Li, Dong et al. 2004; Provot and Schipani 2005; Cohen 2006; Guo, Chung et al. 
2006). Then modulation of Ihh signaling through Fgf/Fgfr3 and Igf1/Igf1r may throw the 
switch to chondrocyte hypertrophy and subsequent osteoblast differentiation (de 
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Crombrugghe, Lefebvre et al. 2001; Kronenberg 2003; Marie 2003; Amizuka, Davidson 
et al. 2004; Provot and Schipani 2005; Cohen 2006). 
 Osteoblast activity and differentiation is controlled by a sequential series of 
transcription factors. Runx2 is one of the main transcription factors controlling 
osteoblasts differentiation and development, and its expression in the mesenchymal cells 
precedes osteoblast differentiation and is sufficient for mesenchymal differentiation 
towards the osteoblast lineage (de Crombrugghe, Lefebvre et al. 2001; Franceschi and 
Xiao 2003; Kronenberg 2003; Li, Dong et al. 2004; Provot and Schipani 2005; Cohen 
2006; Guo, Chung et al. 2006). Osterix (Osx) is another osteoblast-specific transcription 
factor that is a direct downstream target of Runx2 (de Crombrugghe, Lefebvre et al. 
2001; Kronenberg 2003; Koga, Matsui et al. 2005; Provot and Schipani 2005; Cohen 
2006; Baek, Lee et al. 2009). A number of other signals are thought to work in synergy 
with either Runx2 or Osx to promote osteoblast-specific gene expression at later stages 
(Franceschi and Xiao 2003; Koga, Matsui et al. 2005; Baek, Lee et al. 2009). Among the 
genes differentially regulated by these signals are collagen I, which is the primary 
structural element of bone matrix, and osteocalcin, a bone mineralization protein found in 
more mature bone (Franceschi and Xiao 2003; Koga, Matsui et al. 2005; Cohen 2006; 
Deng, Sharff et al. 2008; Baek, Lee et al. 2009). As the bone matures, it becomes 
mineralized with calcium and phosphate, and provides storage for excess levels of these 
minerals. 
 When the bone matures or is restructured, osteoclasts are responsible for 
resorbing bone matrix. They secrete matrix metalloproteinases (MMPs) that degrade the 
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bone and release stored minerals (Delaisse, Andersen et al. 2003; Hou, Troen et al. 2004; 
Cohen 2006). Receptor activator of NFκB (RANK) and RANK ligand (RANKL) are 
mediators of osteoclast differentiation, while cathepsin K (CtsK) and MMPs accounts for 
the majority of the osteoclast activity (Delaisse, Andersen et al. 2003; Hou, Troen et al. 
2004; Feng 2005; Cohen 2006; Logar, Komadina et al. 2007; Boyce and Xing 2008). 
Osteoclast activity is often closely linked with physiological cation levels (Feng 2005; 
Logar, Komadina et al. 2007; Boyce and Xing 2008). Excess calcium is often stored in 
bone and when there are drops in calcium levels osteoclast activity can be increased to 
mobilize calcium stored in bone. 
 Defects in osteoclasts can lead to osteopetrosis. In osteopetrosis a disruption in a 
hydrogen ion pump leads dysfunctional osteoclasts and decreased bone resorption. This 
in turn results in excessive bone formation and bone density (Stark and Savarirayan 
2009). In contrast, elevated osteoclast activity contributes to osteoporosis (Bajaj and Saag 
2003; Cosman 2005; Logar, Komadina et al. 2007; Sipos, Pietschmann et al. 2009). In 
osteoporosis, disruption of estrogen levels can lead in increased osteoclast activity, and 
consequently, increased bone resorption and reduced bone mass. Similarly, the 
parathyroid gland can respond to low calcium by increasing PTH levels which in turn 
stimulate osteoclast activity to mobilize calcium. 
 Bone defects can reflect broader defects beyond the skeleton. Not only can they 
disrupt the overall architecture and structural stability of an organism, a disruption of the 
balance of bone remodeling or bone composition can reflect larger problems in the 
regulation of homeostatic processes. They may indicate changes in ion levels such as 
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calcium or phosphate and hormonal imbalances such as PTH. Dissecting the mechanisms 
of underlying bone defects can be of vital importance to understanding and treating 
broader defects. In the following chapters I will discuss identification of bone defects in 




 The mammalian kidney is a complex organ responsible for removal of 
nitrogenous waste, blood filtration, and regulation of osmolarity, fluid balance and pH. It 
greatly impacts physiological ion homeostasis by controlling the levels of reabsorption or 
excretion of physiological ions like calcium, magnesium and phosphate. The kidney is 
composed of numerous functional units known as nephrons, with more than ~800,000 
nephrons existing in a human kidney (Bankir, Bouby et al. 1989; Reilly and Ellison 2000; 
Di Sole 2008; Jabbour and Goldstein 2008; Thomson and Blantz 2008; Wingert and 
Davidson 2008; Biber, Hernando et al. 2009; Boros, Bindels et al. 2009; Haraldsson and 
Jeansson 2009; Layton, Layton et al. 2009; Wagner, Devuyst et al. 2009; Wang, 
Armando et al. 2009). Each nephron regulates metabolite and electrolyte levels and blood 
pH through distinct subcomponents. The nephron is divided primarily into the 
glomerulus, a tubule, and a collecting duct (Bankir, Bouby et al. 1989; Reilly and Ellison 
2000; Thomson and Blantz 2008; Wingert and Davidson 2008; Haraldsson and Jeansson 
2009; Layton, Layton et al. 2009). The glomerulus is responsible for the initial filtration 
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and concentration of solutes and metabolites from the blood (Bankir, Bouby et al. 1989; 
Thomson and Blantz 2008; Haraldsson and Jeansson 2009).  
 This concentrated glomerular filtrate then passes through the tubules where 
distinct sections of the tubules are responsible for secreting waste and reabsorbing 
different minerals or metabolites, before the remaining filtrate is excreted as waste 
(Bankir, Bouby et al. 1989; Kamel, Cheema-Dhadli et al. 2004; Di Sole 2008; Jabbour 
and Goldstein 2008; Biber, Hernando et al. 2009; Boros, Bindels et al. 2009; Wagner, 
Devuyst et al. 2009; Wang, Armando et al. 2009). Distinct segments of the tubules are 
known for secretion of nitrogenous waste and reabsorption of components such as 
sodium, potassium, glucose, magnesium, calcium, parathyroid hormone, phosphate, and 
aldosterone (Bankir, Bouby et al. 1989; Kamel, Cheema-Dhadli et al. 2004; Di Sole 
2008; Jabbour and Goldstein 2008; Biber, Hernando et al. 2009; Boros, Bindels et al. 
2009; Wagner, Devuyst et al. 2009; Wang, Armando et al. 2009). After filtration, 
secretion and reabsorption in the glomerulus and tubule, the remaining filtrate and waste 
then passes through the collecting duct to be excreted (Bankir, Bouby et al. 1989; Kamel, 
Cheema-Dhadli et al. 2004). 
 Mammalian kidneys are composed of a pronephros and mesonephros at 
embryonic and fetal stages, but are replaced by the characteristic complexity of the 
metanephros in later fetal development (Kuure, Vuolteenaho et al. 2000; Wingert and 
Davidson 2008). In contrast to the mammalian kidney, the teleost and amphibian kidneys 
each represent a much less complex apparatus (Drummond 2004; Zhou and Vize 2004; 
Drummond 2005; Wingert and Davidson 2008). In embryonic and early larval stages the 
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zebrafish kidney is referred to as the pronephros, and comprises only a bilateral pair of 
nephrons (Drummond 2004; Drummond 2005; Wingert and Davidson 2008). At later 
larval stages additional nephrons differentiate from the surrounding mesenchyme to form 
the mesonephros (Drummond 2004; Drummond 2005; Wingert and Davidson 2008). 
Zebrafish and frog pronephric nephrons appear to be anatomically and functionally 
similar to a mammalian nephron. They consist of the same fundamental subunits, a 
glomerulus, a tubule, and a collecting duct (Drummond 2004; Drummond 2005; Wingert 
and Davidson 2008). Furthermore recent work in zebrafish has shown a large degree in 
conservation in the segmental gene expression pattern along the tubule which is largely 
conserved in mammals (Wingert, Selleck et al. 2007; Wingert and Davidson 2008). The 
zebrafish kidney has at least 8 distinct regions of gene expression, many of which are 
comparable to patterns of gene expression in discrete segments of mammalian tubules 
(Wingert, Selleck et al. 2007; Wingert and Davidson 2008). This segmental conservation 
suggests that the zebrafish nephrons are a promising option for studying processes 
governing kidney development and function, and how disruption of these processes leads 
to prevalent renal disorders. 
 Defects in kidney function can have a severe impact on an organism’s 
development and survival, and are evident in a number of primary and secondary 
disorders. An estimated 7.4 million adults are affected by chronic kidney disease 
(National Kidney Foundation 2002) and ~90,000 new cases of end-stage renal disease 
(ESRD) resulting from diabetes, hypertension and other disorders appear in the U.S. each 
year (National Kidney Foundation 2002). Treatment of ESRD is estimated to cost more 
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than $22 billion annually (United States Renal Data System 2003), and treatment of less 
severe manifestations of renal dysfunction, such as kidney stone formation, is estimated 
to cost more than $1.8 billion annually (Clark, Thompson et al. 1995; Kuizon and 
Salusky 1999). Furthermore, renal dysfunction can lead to secondary developmental 
defects in growth and bone development, as evidenced in children with chronic renal 
failure (Kuizon and Salusky 1999) and renal osteodystrophy (Gonzalez and Martin 2001; 
Kuizon and Salusky 2002). Renal dysfunction results in significant biomedical and 
economic consequences. Improved understanding of the mechanisms and consequences 
of renal dysfunction can lead to new treatments of related disorders. The zebrafish kidney 
therefore presents an opportunity to advance understanding of kidney development and 
function, as well as potentially identifying new methods in treating kidney disorders. 
 
Physiological Ion Homeostasis 
 As discussed in previous sections, both bone and the kidney impact physiological 
ion homeostasis. The kidney is the organ responsible for regulating filtration and 
reabsorption of ions from the blood. Bone acts as a reservoir of ions like calcium and 
phosphate in its matrix. Physiological ion homeostasis largely represents a complex 
interplay between bone and kidney in the intricate regulation of ion levels. In mammals a 
third component, the parathyroid gland, also has a strong influence on ion homeostasis 
(Akerstrom, Hellman et al. 2005; Zajac and Danks 2008). In teleost fish it is the 
corpuscles of Stannius (CS) which also impacts ion homeostasis (Krishnamurthy 1976; 
Lafeber, Flik et al. 1988; Pandey 1994; Greenwood, Flik et al. 2009). These three 
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components regulate ion homeostasis through a number of tightly controlled endocrine 
signaling molecules. Many of these molecules can have multiple effects on different 
components of the parathyroid-bone-kidney axis or the CS-bone-kidney axis. Some of 
these important regulators include parathyroid hormone (PTH), stanniocalcin (STC), 
calcitriol, FGF23, cation-sensing receptor (CaSR), and the ions themselves (Lafeber, Flik 
et al. 1988; Fujita 2000; D'Souza-Li 2006; Gal-Moscovici and Sprague 2007; Bischoff-
Ferrari and Staehelin 2008; Doyle and Jan de Beur 2008; Egbuna and Brown 2008; 
Talmage and Mobley 2008; Wolff, Jones et al. 2008; Greenwood, Flik et al. 2009; 
Samadfam, Richard et al. 2009; Theman and Collins 2009; Tsagalis, Psimenou et al. 
2009). Misregulation of homeostasis can lead to a number of defects, ranging from 
brittle, poorly mineralized bone (Bajaj and Saag 2003; D'Souza-Li 2006; Egbuna and 
Brown 2008; Sipos, Pietschmann et al. 2009) or premature bone formation (Schipani, 
Kruse et al. 1995; Karaplis, He et al. 1998; D'Souza-Li 2006; Egbuna and Brown 2008) 
to kidney stone formation (Parmar 2004; Stechman, Loh et al. 2007; Moochhala, Sayer et 
al. 2008; Worcester and Coe 2008), chronic kidney disease (Gonzalez and Martin 2001; 
Kuizon and Salusky 2002; National Kidney Foundation 2002; Gal-Moscovici and 
Sprague 2007; Williams 2009), renal failure (Clark, Thompson et al. 1995; Kuizon and 
Salusky 1999; Gonzalez and Martin 2001; Kuizon and Salusky 2002; Goodman 2006; 
Rodriguez, Canadillas et al. 2006; Doumouchtsis, Perrea et al. 2009; Williams 2009) and 
severe growth retardation (Clark, Thompson et al. 1995). 
 In terrestrial mammals the parathyroid gland, a primary regulator of calcium 
homeostasis, controls secretion of the anti-hypocalcemic factor PTH. Many of the 
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disorders associated with imbalances in ion homeostasis often involve dysfunction of the 
parathyroid gland and exhibit either primary or secondary hypo- or hyperparathyroidism. 
Within the parathyroid production of PTH is regulated by the cation-sensing receptor 
(CaSR), with stimulation of PTH occurring in response to detection of decreased blood 
calcium levels by CaSR. Conversely, when high blood calcium levels are detected, 
inhibition of PTH production occurs (Akerstrom, Hellman et al. 2005; D'Souza-Li 2006; 
Egbuna and Brown 2008; Zajac and Danks 2008; Theman and Collins 2009). 
Hyperparathyroidism is indicative of over-stimulation of PTH production and 
consequentially often leads to hypercalcemia and bone loss (Fujita 2000; D'Souza-Li 
2006; Maeda, Fortes et al. 2006; Egbuna and Brown 2008). Conversely, 
hypoparathyroidism is indicative of decreased PTH production, leads to hypocalcemia 
and has associated phenotypes of tetany, seizures, and decreased sensation in extremities 
(Fujita 2000; Chen and Goodman 2004; D'Souza-Li 2006; Egbuna and Brown 2008).  
 PTH is both an anti-hypocalcemic and anti-hyperphosphatemic hormone that acts 
on bone and kidney to effect changes in serum calcium levels (Schipani and Provot 2003; 
Akerstrom, Hellman et al. 2005; Cohen 2006; Talmage and Mobley 2008; Zajac and 
Danks 2008; Datta and Abou-Samra 2009). Bone acts as a reservoir for excess calcium 
and when increased PTH signals to bone, osteoclasts are activated and increased bone 
resorption is triggered (Akerstrom, Hellman et al. 2005; Cohen 2006; Talmage and 
Mobley 2008). This bone resorption releases calcium and phosphate stored in the bone 
matrix. In the kidney PTH contributes to the regulation of divalent cation transport and 
reabsorption, as well as signaling an increase in phosphate excretion (Akerstrom, 
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Hellman et al. 2005; Cohen 2006; Doyle and Jan de Beur 2008; Quarles 2008; Talmage 
and Mobley 2008; Samadfam, Richard et al. 2009; Williams 2009). This increased 
phosphate excretion lowers serum phosphate levels which in turn increases the calcium to 
phosphate ratio and leads to more free calcium in the blood (Cohen 2006; Doyle and Jan 
de Beur 2008; Quarles 2008; Vezzoli, Soldati et al. 2009). PTH also activates a vitamin D 
hydroxylase in the kidney to promote hydroxylation of 25-hydroxy-vitamin D into its 
active form (1,25-dihydroxy vitamin D), which is also known as calcitriol (Cohen 2006; 
Gal-Moscovici and Sprague 2007; Bischoff-Ferrari and Staehelin 2008; Wolff, Jones et 
al. 2008). Calcitriol then acts on the intestine to increase calcium absorption (Cohen 
2006; Gal-Moscovici and Sprague 2007; Bischoff-Ferrari and Staehelin 2008; Wolff, 
Jones et al. 2008). 
 In addition to acting as the calcium sensor in the parathyroid to control the set 
point of physiologic calcium by regulating PTH secretion, CaSR is also located in the 
kidney and in bone (Brown 2007; Brown and Lian 2008; Vezzoli, Soldati et al. 2009). By 
regulating PTH secretion in the parathyroid, CaSR indirectly affects divalent cation 
transport in the kidney. However, CaSR expression in the kidney also leads to a direct 
role in regulating divalent cation transport (Brown 2007; Vezzoli, Soldati et al. 2009). 
The role of CaSR in bone is debatable as conflicting reports exist about its presence in 
osteoblasts or osteoblast-like cells (Pi, Garner et al. 2000; Pi and Quarles 2005; Brown 
and Lian 2008). However, a CaSR-like receptor does appear to be present in osteoblasts 
and stimulates proliferation, differentiation and mineralization at high calcium levels (Pi, 
Garner et al. 2000; Pi and Quarles 2005). 
 15
 One additional factor that has been characterized recently is FGF23 (Riminucci, 
Collins et al. 2003; Segawa, Kawakami et al. 2003; Shimada, Hasegawa et al. 2004; 
Sitara, Razzaque et al. 2004; Doyle and Jan de Beur 2008; Gattineni, Bates et al. 2009; 
Samadfam, Richard et al. 2009; Tsagalis, Psimenou et al. 2009). Expression of FGF23 
has been found in both the bone and kidney, and it is also referred to as phosphatonin 
(Riminucci, Collins et al. 2003; Segawa, Kawakami et al. 2003; Shimada, Hasegawa et 
al. 2004; Sitara, Razzaque et al. 2004; Doyle and Jan de Beur 2008; Quarles 2008; 
Gattineni, Bates et al. 2009; Samadfam, Richard et al. 2009; Tsagalis, Psimenou et al. 
2009). As the name implies, FGF23 is an anti-hyperphosphatemic factor which acts on 
the kidney to control phosphate uptake. FGF23 regulates the expression of the Na/Pi 
cotransporters in the kidney (Gattineni, Bates et al. 2009; Samadfam, Richard et al. 
2009). These transporters control phosphate uptake and reabsorption in the kidney, and 
are suppressed by circulating levels of FGF23 (Gattineni, Bates et al. 2009; Samadfam, 
Richard et al. 2009). Though FGF23 expression has been detected at sites within the 
kidney, its expression is thought to be the most prevalent in osteocytes in bone (Shimada, 
Hasegawa et al. 2004; Sitara, Razzaque et al. 2004; Doyle and Jan de Beur 2008; Quarles 
2008; Samadfam, Richard et al. 2009; Tsagalis, Psimenou et al. 2009). Activating 
mutations of FGF23 (Segawa, Kawakami et al. 2003) show that high levels of FGF23 
lead to hypophosphatemia, whereas ablation of FGF23 causes hyperphosphatemia 
(Sitara, Razzaque et al. 2004).  Furthermore, FGF23 is also known to inhibit production 
of calcitriol in the kidney, thereby counteracting effects of PTH with respect to phosphate 
homeostasis and intestinal calcium absorption. It has been hypothesized that the activities 
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of FGF23 and PTH are antagonistic towards one another and calcitriol is used to maintain 
a balance (Shimada, Hasegawa et al. 2004), however that remains to be definitively 
determined.  
 In terrestrial animals, whose only source of calcium is from diet, PTH acts as anti-
hypocalcemic factor to promote storage of calcium in bone and prevent too much loss 
through urinary excretion. In contrast, fish are surrounded by an abundant external supply 
of calcium and magnesium and must prevent an overload of these ions to their systems. 
The corpuscles of Stannius (CS) represent a fish-specific gland primarily responsible for 
prevention of this overload (Krishnamurthy 1976; Lafeber, Flik et al. 1988; Pandey 1994; 
Greenwood, Flik et al. 2009). It does this through the secretion of hormones known as 
stanniocalcins. As opposed to PTH, these factors have both anti-hypercalcemic and anti-
hypophosphatemic activity and regulate the transport of calcium across gills and the 
reabsorption of renal phosphate (Lafeber, Flik et al. 1988; Pandey 1994; Greenwood, Flik 
et al. 2009). Together this provides a mechanism in which excess circulating calcium can 
combine with physiologic phosphate to form deposits on bone, and helps limit the uptake 
of calcium from external media (Lafeber, Flik et al. 1988; Pandey 1994; Greenwood, Flik 
et al. 2009). 
 As can be observed with the antagonistic activities of PTH and FGF23 with 
respect to phosphate regulation, these factors do not act independently of one another. 
Rather an intricate balance exists between them to maintain set levels of ion homeostasis. 
Furthermore, for the sake of simplicity the factors discussed here are only a subset of the 
mechanisms by which ion homeostasis is regulated. Many other components exist which 
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modify and regulate these signals in a complex interplay between the parathyroid, the 
kidney and bone to maintain set ion levels.  
 
The TRP family of ion channels 
 The TRP family members of ion channels have diverse functions and are divided 
into multiple subfamilies, TRPC (Canonical), TRPV (Vanilloid), TRPP (Polycystin), 
TRPML (Mucolipin), TRPA (Ankyrin), TRPN (NOMPC), and TRPM (Melastatin) 
channels (Pedersen, Owsianik et al. 2005; Venkatachalam and Montell 2007). All TRP 
superfamily members contain six putative transmembrane domains, have varying levels 
of permeability to cations and exhibit a wide array of cation selectivities (Pedersen, 
Owsianik et al. 2005; Venkatachalam and Montell 2007). The channels form homo- or 
heteromultimeric complexes with each other or with close family members. However, 
possibly the most distinguishing aspects of the TRP superfamily members are the diverse 
ways these channels can be activated and their responsiveness to disparate signals. TRP 
channels have been identified with responses to stimulation to touch, sound, light, 
temperature, and chemicals (Pedersen, Owsianik et al. 2005; Venkatachalam and Montell 
2007). TRP channels are also known to have roles in regulation of cations at the 
organismal and cellular levels and are often vital to cell survival in neuronal and other 
cell types (Nadler, Hermosura et al. 2001; Walder, Landau et al. 2002; Aarts, Iihara et al. 
2003; Monteilh-Zoller, Hermosura et al. 2003; Schmitz, Perraud et al. 2003; Clark, 
Langeslag et al. 2006; Krapivinsky, Mochida et al. 2006; Su, Agapito et al. 2006; Wei, 
Sun et al. 2007). 
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 The TRPC subfamily consists of 7 members and represents nonselective Ca2+ 
permeable cation channels which often require PLC for activation (Pedersen, Owsianik et 
al. 2005; Venkatachalam and Montell 2007). These channels are often broadly expressed 
but have diverse functions. One family member, TRPC2 has been identified to respond in 
a pheromone response in mice, where male knockouts fail to show characteristic 
aggression towards other invading male mice (Liman, Corey et al. 1999; Leypold, Yu et 
al. 2002; Stowers, Holy et al. 2002). Another member, TRPC6, has been identified as the 
cause of a kidney disorder, focal and segmental glomerulosclerosis (FSGS) (Reiser, Polu 
et al. 2005; Winn, Conlon et al. 2005). Here a breach in the capillary/kidney permeability 
barrier occurs and causes progression towards end stage renal disease. Failure of TRPC6 
to interact with nephron and podocin in the foot processes of glomeruli has been 
proposed as the likely cause of this disease (Reiser, Polu et al. 2005; Winn, Conlon et al. 
2005). 
 The TRPV subfamily contains 6 members, some of which are thermosensitive and 
also responsive compounds such as capsaicin (spicy foods), piperine (black pepper), and 
allicin (garlic) (Caterina, Schumacher et al. 1997; Voets, Prenen et al. 2001; Yue, Peng et 
al. 2001; Hoenderop, van Leeuwen et al. 2003; Muraki, Iwata et al. 2003; Nilius 2003; 
Macpherson, Geierstanger et al. 2005; McNamara, Randall et al. 2005). The TRPV 
family members have moderate Ca2+ permeability, but only TRPV5-6 are highly selective 
for Ca2+ with their activity tightly regulated by intracellular calcium concentration 
(Voets, Prenen et al. 2001; Yue, Peng et al. 2001; Nilius 2003). TRPV5 is expressed in 
the kidney and knockout leads to increased Ca2+ absorption due to an inability to reabsorb 
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calcium (Hoenderop, van Leeuwen et al. 2003). Other TRPV members are activated by 
cell swelling, cell shearing or hypotonicity (Muraki, Iwata et al. 2003; Nilius, Watanabe 
et al. 2003; Nilius, Vriens et al. 2004; Liu, Bandyopadhyay et al. 2006). They function in 
mechanosensing and osmosensing (Liedtke and Friedman 2003). 
 The TRPP subfamily is best characterized by TRPP1 and TRPP2, mutations in 
which lead to polycystic kidney disease (PKD) and autosomal dominant polycystic 
kidney disease (ADPKD), respectively (Mochizuki, Wu et al. 1996; Peral, San Millan et 
al. 1996; Sutters and Germino 2003). They are localized to primary cilia where they are 
thought to make cilia capable of sensing fluid flow, osmolarity, and mechanical stretch, 
by responding to these stimuli with Ca2+ elevation (Pennekamp, Karcher et al. 2002; 
McGrath, Somlo et al. 2003; Nauli, Alenghat et al. 2003). 
 The TRPML subfamily, consists of three members, but only the first member, 
TRPML1 (Mucolipin 1), has been well characterized (Sun, Goldin et al. 2000; Bach 
2001; Altarescu, Sun et al. 2002; LaPlante, Falardeau et al. 2002; LaPlante, Ye et al. 
2004). Mutations in mucolipin1 are known to cause a lysosomal storage disorder known 
as Mucolipidosis IV, and this disease leads to severe neurodegeneration (Sun, Goldin et 
al. 2000; Bach 2001; Altarescu, Sun et al. 2002; LaPlante, Falardeau et al. 2002; 
LaPlante, Ye et al. 2004). Mucolipin 1, which is localized to lysosomal membranes and 
permeable to monovalent cations is thought to act as a proton channel that regulates 
lysosomal pH (Sun, Goldin et al. 2000; Bach 2001; Altarescu, Sun et al. 2002; LaPlante, 
Falardeau et al. 2002; LaPlante, Ye et al. 2004). 
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 The TRPA and TRPN family members are less well characterized. TRPA only 
consists of 1 member, which is localized in the tips of stereocilia (Corey, Garcia-
Anoveros et al. 2004). Knockdown of TRPA1 in zebrafish and mouse embryos reduces 
auditory-evoked potentials, therefore it is hypothesized that TRPA1 may play a role in 
auditory response (Corey, Garcia-Anoveros et al. 2004). The TRPN subfamily does not 
have any mammalian homologues, though members exist in flies, worms and zebrafish 
(Walker, Willingham et al. 2000; Sidi, Friedrich et al. 2003). TRPN1 is expressed in the 
hair cells of the zebrafish ear and its knockdown also induces sound-evoked potentials 
(Sidi, Friedrich et al. 2003).  
 Of most relevance to my work is the TRPM subfamily of cation channels, which 
is composed of 8 members (Kraft and Harteneck 2005; Pedersen, Owsianik et al. 2005; 
Venkatachalam and Montell 2007). The founding member, TRPM1 (melastatin1), was 
initially identified because its expression was inversely correlated with the metastatic 
potential of melanomic cell lines (Duncan, Deeds et al. 1998; Duncan, Deeds et al. 2001; 
Miller, Du et al. 2004). TRPM2 is unique among TRP members in that it has an ADP-
ribose pyrophosphatase domain linked to its C-terminus. It is a Ca2+ permeable cation 
channel that is activated by ADP-ribose and NAD, and is thought to be a sensor of 
oxidative stress (Perraud, Fleig et al. 2001; Sano, Inamura et al. 2001; Mori, Wakamori et 
al. 2002). TRPM3 is a constitutively active Ca2+ and Mn2+ permeable cation channel with 
activity enhanced by cell swelling and extracellular hypotonicity (Grimm, Kraft et al. 
2003; Lee, Chen et al. 2003). TRPM8 is rare in that it is a cold activated cation channel. 
It is also responsive to menthol, eucalyptol and icilin and its main function is considered 
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to be as a thermosensor in sensory neurons (Grimm, Kraft et al. 2003; Lee, Chen et al. 
2003). TRPM4 and TRPM5 are calcium-activated monovalent cation selective channels 
(VCAMs). Their activity is thought to be modulated by changes in membrane potentials 
(Launay, Fleig et al. 2002; Hofmann, Chubanov et al. 2003; Nilius, Prenen et al. 2003; 
Prawitt, Monteilh-Zoller et al. 2003). Both TRPM4 and 5 are thermal sensitive, and 
TRPM5 is an established taste-transduction signal. In TRPM5 knockout mice, their 
responses to sweet and bitter taste are greatly reduced (Perez, Huang et al. 2002; Zhang, 
Hoon et al. 2003).  
 Among the TRP superfamily, and even within the TRPM subfamily, TRPM6 and 
TRPM7 are unique. They are closely related channels that have alpha-kinase domains 
linked to their C-terminus that regulate channel activity (Nadler, Hermosura et al. 2001; 
Runnels, Yue et al. 2001; Chubanov, Mederos y Schnitzler et al. 2005; Schlingmann, 
Waldegger et al. 2007). Both TRPM6 and TRPM7 are preferentially permeable to a 
number of divalent cations, including Mg2+ and Ca2+ (Nadler, Hermosura et al. 2001; 
Monteilh-Zoller, Hermosura et al. 2003; Schmitz, Perraud et al. 2003; Voets, Nilius et al. 
2004; Li, Jiang et al. 2006; Topala, Groenestege et al. 2007). Their high degree of 
permeability to Mg2+ highlights the importance of the channels in Mg2+ homeostasis. For 
functional channels to form, TRPM6 must form multimeric complexes and is generally 
thought to multimerize obligately with TRPM7 (Chubanov, Waldegger et al. 2004; 
Schmitz, Dorovkov et al. 2005). Other studies suggest homomeric TRPM6 complexes 
may be active as well (Fujiwara and Minor 2008). By contrast, TRPM7 can function as 
either a heteromeric or homomeric channel (Runnels, Yue et al. 2001; Monteilh-Zoller, 
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Hermosura et al. 2003; Schmitz, Dorovkov et al. 2005; Li, Jiang et al. 2006; Fujiwara and 
Minor 2008).  
 TRPM6 channels are found primarily in organs at sites that regulate magnesium 
absorption, such as the intestinal brush border and the renal distal convoluted tubule 
(DCT) (Voets, Nilius et al. 2004; Fonfria, Murdock et al. 2006; Groenestege, Hoenderop 
et al. 2006; Kunert-Keil, Bisping et al. 2006). In humans, mutant forms of TRPM6 are 
linked to hypomagnesemia with secondary hypocalcemia (HSH or HOMG) 
(Schlingmann, Weber et al. 2002; Walder, Landau et al. 2002). In HSH, a decrease in 
renal and intestinal reabsorption of magnesium is observed, resulting in a drop in 
physiological magnesium levels. This leads to inhibition of the cation-sensing receptor 
(CaSR) in the parathyroid gland which in turn results in decreased parathyroid hormone 
production and a secondary drop in calcium levels (Vetter and Lohse 2002; Iwasaki, Asai 
et al. 2007; Alexander, Hoenderop et al. 2008). Thus, TRPM6 is the primary regulator of 
whole-organism magnesium homeostasis. However the likely necessity of 
heteromultimerizing with TRPM7 suggests that TRPM7 may be of equal importance to 
the process. 
 TRPM7 channels are expressed ubiquitously and regulate cellular magnesium 
homeostasis (Aarts, Iihara et al. 2003; Wei, Sun et al. 2007). The importance of TRPM7 
to cellular magnesium homeostasis was established using DT40 cells lacking TRPM7 
(Schmitz, Perraud et al. 2003). These cells were growth-arrested and had depleted Mg2+ 
levels, however with supplementation of extracellular magnesium, the growth arrest and 
lethality were rescued. In addition to its role in regulating cellular magnesium influx, 
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other studies have demonstrated the importance of the Ca2+ permeability of TRPM7. One 
group has showed that TRPM7-mediated Ca2+ currents are activated by reactive 
oxygen/nitrogen species (ROS) lead to death of anoxic neurons (Aarts, Iihara et al. 2003). 
Others identified the importance of TPRM7-mediated Ca2+ influx in the proliferation of 
human retinoblastoma cells (Hanano, Hara et al. 2004). Additionally, other groups have 
identified the importance of a localized TRPM7-mediated influx of Ca2+ associated with 
changes in cell adhesion, cell spreading and actomyosin contractility (Clark, Langeslag et 
al. 2006; Su, Agapito et al. 2006).  
 While many roles have been established for TRPM7 channel activity, other roles 
have been established for the kinase domain. This domain is known to be the primary 
regulator of channel activity through auto-phosphorylation at multiple sites and its 
activity is dependent on intracellular Mg2+ and Mg-nucleotide concentrations 
(Ryazanova, Dorovkov et al. 2004; Takezawa, Schmitz et al. 2004; Demeuse, Penner et 
al. 2006). However, in addition to this auto-regulation, the kinase domain has other 
targets within the cell (Dorovkov and Ryazanov 2004; Clark, Langeslag et al. 2006). One 
of the initial identifications of TRPM7 was through the interaction of the kinase with 
PLCβ1 (Runnels, Yue et al. 2001; Dorovkov and Ryazanov 2004; Clark, Langeslag et al. 
2006). Other identified targets include myosin IIA heavy chain and annexin I (Dorovkov 
and Ryazanov 2004; Clark, Langeslag et al. 2006).  
 Most of the investigations into TRPM7 have focused on its impact at the cellular 
level and the early lethality associated with TRPM7 mutations in mammalian systems has 
precluded analyses of roles of TRPM7 at the organismal level (Jin, Desai et al. 2008). 
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The work presented herein focuses on the impact TRPM7 has at the organismal level by 
making use of zebrafish trpm7 mutants as an animal model. In the following chapters I 
will discuss the identification and cloning of trpm7 mutants, characterize growth and 
skeletogenic defects, and demonstrate the formation of kidney stones in trpm7 mutants. 
Furthermore, I will demonstrate the impact of trpm7 on pronephric activity and 
physiologic cation homeostasis. Together this work provides a substantial step towards 
understanding the impact of TRPM7 at the organismal level. 
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Chapter 2: Defective Skeletogenesis with Kidney Stone Formation in Dwarf 
Zebrafish Mutant for trpm7 
 
Summary 
 Development of the adult form requires coordinated growth and patterning of 
multiple traits in response to local gene activity as well as global endocrine and 
physiological effectors. An excellent example of such coordination is the skeleton. 
Skeletal development depends on the differentiation and morphogenesis of multiple cell 
types to generate elements with distinct forms and functions throughout the body 
(Karsenty and Wagner 2002; Fisher, Jagadeeswaran et al. 2003; Kronenberg 2003). We 
show that zebrafish touchtone/nutria mutants exhibit severe growth retardation and gross 
alterations in skeletal development in addition to embryonic-melanophore and touch 
response defects (Arduini and Henion 2004; Cornell, Yemm et al. 2004). These 
alterations include accelerated endochondral ossification but delayed intramembranous 
ossification, as well as skeletal deformities. We show that the touchtone/nutria phenotype 
results from mutations in trpm7, which encodes a transient receptor potential (TRP) 
family member that functions as both a cation channel and kinase. We find trpm7 
expression in the mesonephric kidney and show that mutants develop kidney stones, 
indicating renal dysfunction. These results identify a requirement for trpm7 in growth and 
skeletogenesis and highlight the potential of forward genetic approaches to uncover 
physiological mechanisms contributing to the development of adult form. 
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Results and Discussion 
 Genetic screens for ethyl-N-nitrosurea-induced mutations affecting zebrafish 
postembryonic development uncovered the nutriaj124e2 mutant, named for its small size, 
odd shape, and tendency to swim near the surface (Figures 2.1A and 2.1B). As embryos 
and early larvae (2-5 days post fertilization [dpf]), nutria are comparable in size to wild-
type siblings, but during later development they exhibit a severe growth deficit (Figure 
2.1C). Craniofacial and trunk-body proportions are altered, although other external 
features (e.g. scales, fins, and the complement of adult pigment cells) are not grossly 
abnormal. To identify the locus causing this dwarf phenotype, we mapped the nutria 
mutation to chromosome 18 in the vicinity of touchtone (tct) (Arduini and Henion 2004; 
Cornell, Yemm et al. 2004). Both tct and nutria mutants exhibit embryonic melanophore 
deficiencies and touch unresponsiveness prior to hatching. Complementation tests 
confirmed that nutria and tct are allelic. Fine mapping of the critical region revealed, 
among other genes, trpm7, which encodes an ortholog of the transient receptor potential 
(TRP) melastatin-7 dual-function cation channel and kinase (0/2889 recombinants) (Wolf 
2004). Although TRPM7 has not been implicated in growth previously, a member of this 
family, TRPM1 (melastatin), is expressed in human melanocytic nevi (Duncan, Deeds et 
al. 1998), and zebrafish melanophores require tct cell autonomously (Arduini and Henion 
2004; Cornell, Yemm et al. 2004). 
 Our data show that trpm7 corresponds to tct. Sequencing trpm7 cDNAs revealed 
premature stop codons in the severe alleles tctj124e1 and tctb508 (Figure 2.S1D and 2.S1E). 
Moreover, the injection of wild-type embryos with a trpm7 splice-blocking morpholino 
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oligonucleotide results in both melanophore deficiencies and touch unresponsiveness and 
thus phenocopies the mutant (Figure 2.S1A-2.S1C). Finally TRPM7 acts as an inwardly 
rectifying cation channel with broad specificity but high affinity for Mg2+ and Ca2+, 
suggesting that manipulating divalent-cation availability might rescue embryonic 
phenotypes of trpm7 mutants (Monteilh-Zoller, Hermosura et al. 2003; Schmitz, Perraud 
et al. 2003). Supplemental Mg2+ partially rescued melanophore development, whereas 
supplemental Ca2+ partially rescued melanophore development and touch responsiveness 
(Figures 2.1D-2.1F; Figure 2.S2). Thus, trpm7 is the gene affected in tct mutants. 
 To clarify the mode(s) of trpm7 activity, we examined trpm7 expression in wild-
type embryos and larvae. Consistent with previous observations, we detected widespread 
trpm7 expression at embryonic stages, including in the central nervous system, 
pronephros, lens, and other tissues (The Zebrafish Information Network 2005; data not 
shown). In metamorphic larvae, transcripts were abundant in liver, mesonephric kidney 
tubules, and corpuscles of Stannius, which are teleost glands that contribute to calcium 
homeostasis (Krishnamurthy 1976) (Figures 2.2A-2.2C). In contrast to severe alleles, 
trpm7j124e2 (nutria) individuals are viable, allowing us to assess functional consequences 
of trpm7 mutation during postembryonic development. Consistent with kidney expression 
of trpm7, histological examination of trpm7j124e2 mutant larvae revealed mineralization 
within mesonephric tubules (Figures 2.2T and 2.2X). These data suggest that altered 
trpm7 function in the kidney, in the corpuscles of Stannius, or in both affects whole-
organism cation homeostasis and leads to nephrolithiasis. 
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 Because dwarfism syndromes in humans are associated with a range of skeletal 
defects (Hall 2002) and cation homeostasis affects bone development and maintenance 
(Dvorak and Riccardi 2004), we asked whether the growth deficit and disproportionality 
of trpm7j124e2 mutants is associated with changes in ossification. A comprehensive 
analysis of 87 bones between 9 and 51 dpf revealed extensive re-alterations in 
ossification sequence between wild-type and mutant larvae (Figures 2.3 and 2.4). Among 
numerous examples of sequence reordering is the epural bone of the caudal fin, which is 
the 78th bone to ossify in the wild-type but only the 32nd to ossify in trpm7 mutants. 
Conversely, the maxilla is the 15th bone to ossify in the wild-type but the 40th to ossify in 
trpm7 mutants. Thus, trpm7+ is essential for the normal sequence of ossification. 
 To better understand ossification changes, we categorized bones according to 
function and anatomical location as well as cellular origin. The most dramatic differences 
were between endochondral bones, which develop through mineralization of a cartilage 
model, and intramembranous bones, which develop directly, without a cartilage model 
(Cubbage 1996; Karsenty and Wagner 2002; Bird and Mabee 2003). In trpm7 mutants, 
endochondral bones (red connectors in Figure 2.4A) appeared on average earlier in the 
ossification sequence than they did in the wild-type, whereas intramembranous bones 
(green connectors) appeared on average later. Dissociation of endochondral and 
intramembranous ossification is exemplified by the caudal complex, in which the 
endochondral hypurals and epural ossify much earlier in trpm7 mutants compared to the 
wild-type, whereas the intramembranous urostyle, centra, and other bones ossify much 
later in trpm7 mutants (Figures 2.3A–2.3H). Precocious endochondral ossification is 
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similarly evident in the suspensorium and the branchial arches of trpm7 mutants (Figures 
2.3I–2.3P), whereas delayed intramembranous ossification is apparent for several bones 
of the anterior head (Figures 2.3Q–2.3V). The accelerated ossification of endochondral 
bones and the delayed ossification of intramembranous bones reflect order in the 
ossification sequence as well as absolute timing. One can most easily visualize these 
timing differences by plotting how genotype affects the likelihood of bones being ossified 
at any given age against the statistical significance of these differences (Figures 2.4B and 
2.4C). Defects in ossification timing do not simply reflect growth retardation; even 
severely runted wild-type fish develop skeletal elements of normal shape without 
premature ossification (Figure 2.S4). 
 Furthermore, functional-anatomical units in close proximity were found to be 
differentially affected, even after we controlled for the relative contributions of 
endochondral and intramembranous bones within these units. For example, otic bones are 
accelerated, whereas orbital bones are delayed, despite the anatomical proximity of these 
bones and their similar endochondral and intramembranous compositions (Figure 2.4C; 
Table 2.S1). Finally, trpm7 mutants exhibited skeletal dysplasia, including extreme 
malformation of the Weberian (auditory) apparatus and the ribs, compressed vertebrae (of 
normal number), and kinks in the posterior vertebral column (Figures 2.3D, 2.3H, 2.3S, 
and 2.3W). 
 We have demonstrated that trpm7 is essential for growth and skeletogenesis 
during the zebrafish larval-to-adult transition and for melanophore development and 
touch response during embryogenesis. trpm7 expression in kidney and corpuscles of 
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Stannius, as well as the presence of kidney stones in trpm7 mutants, support a model in 
which effects on growth and skeletogenesis reflect physiological regulation of cation 
homeostasis. These effects may be analogous to those of parathyroid 
hormone/parathyroid hormone receptor type 1 (PTHR1) regulation of calcium 
homeostasis in mammals, in which changes in PTHR1 signaling or downstream effectors 
such as Runx2 can lead to premature endochondral ossification (Schipani, Kruse et al. 
1995; Karaplis, He et al. 1998; Takeda, Bonnamy et al. 2001; Ueta, Iwamoto et al. 2001). 
However, this model does not readily explain the delayed intramembranous ossification 
observed in trpm7 mutants. Although the precise functions of trpm7 in promoting normal 
ossification sequence and timing, as well as melanophore development and touch 
response, remain to be elucidated, our analyses reveal important roles for trpm7 in the 




Fish Stocks and Maintenance 
 Mutations were induced in wild-type AB, SJD, and wikut genetic backgrounds by 
standard methods of ethyl-N-nitrosourea mutagenesis. Fish were reared at 28.5˚C and fed 
rotifers, paramecia, or dry flake food, as appropriate. For growth series of wild-type fish 
and nutria mutants, fish were reared individually from embryonic through adult stages 
and fed ad libitum to eliminate competition. For staining series, wild-type and mutant 
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individuals were sorted at 3 dpf and then reared separately at equivalent densities to 
minimize variation in growth rates within each genotype. 
 
Skeletal Staining and Classification 
 Fish were fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS) for 
48 hr and dehydrated over 2 days to 100% ethanol. They were then stained with Alcian 
blue for cartilage, digested with trypsin, and stained with Alizarin red for bone according 
to the standard protocol for fish larvae (Potthoff 1984). Fish were transferred to 100% 
glycerol over 1 week for analysis and storage. For calcein staining, we fixed larvae with 
4% paraformaldehyde in PBS, embedded them in OCT, and collected cryosections on 
Fisherbrand Superfrost Plus slides. After they were dried and rinsed in PBS, slides were 
immersed in 0.1% calcein in PBS for 10 min, rinsed extensively in PBS, and 
coverslipped. The classification of bones by method of ossification and anatomical-
functional units followed that used by references (Cubbage 1996; Bird and Mabee 2003; 
Fleming, Keynes et al. 2004). 
 
Genetic Mapping and Sequencing 
 Meiotic mapping was performed by standard methods using haploid and diploid 
mapping panels constructed with AB and wik mapping strains (panel sizes: trpm7 j124e2, 
1400 haploid embryos; trpm7 b722, 1000 diploid embryos; trpm7b508, 435 haploid 
embryos; and trpm7b508, trpm7 os1, and trpm7 os2, 54 diploid embryos). For identification 
of mutant lesions, polymerase-chain-reaction (PCR) products of trpm7 cDNAs were 
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sequenced directly and compared with sequences derived from the corresponding 
mutagenized genetic background. 
 
Morpholino-Based Gene Knockdown 
 For morpholino-injection experiments, eggs were obtained from natural matings 
of wild-type fish of the ZDR strain (Scientific Hatcheries, Huntington Beach, California). 
Morpholino oligonucleotides (GeneTools, Sumerton, Oregon) were diluted to 20 mg/ml 
in Danieau buffer and then to 0.8 mg/ml in 0.2 M KCl for injection. We designed a 
morpholino (GTG TGT GAG ATT TAC TCT GCT GTT C) to interfere with splicing 
(Draper, Morcos et al. 2001) at the junction between exon 12 and intron 12. Embryos 
were injected at the 2- to 4-cell stage with approximately 5 nl of 0.8 mg/ml trpm7 
morpholino or of the standard negative control morpholino (GeneTools). Sequencing of 
morpholino-injected embryos confirmed failed splicing of intron 12, and this failure 
resulted in a frameshift and a premature stop codon (not shown). With all morpholinos, 
we observed approximately 5% mortality before 12 hpf, presumably from injection 
wounds. At all stages, embryos injected with standard negative-control morpholino 
appeared identical to uninjected embryos (not shown). A phenotype of highly reduced 
melanophore differentiation throughout the embryo (shown in Figure 2.S1) was observed 
in 80% of injected embryos (n = 60), with other embryos showing a less-pronounced 
phenotype. Limited morpholino perdurance precluded testing for effects of morpholino 
knockdown on late-developing kidney and ossification phenotypes. 
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In Situ Hybridization 
 Whole-mount in situ hybridization, with minor modifications, followed (Quigley, 
Turner et al. 2004). In brief, larvae were fixed over 2 nights in 4% paraformaldehyde and 
1% DMSO in PBS, transferred to methanol, and then rehydrated to PBST (PBS with 
0.2% Tween-20). Larvae were treated for 30 min with 20 mg/ml proteinase-K in PBST 
containing 1% DMSO, postfixed for 20 min in 4% paraformaldehyde in PBST, washed in 
PBST, and then washed three times in a hybridization solution lacking transfer RNA 
(tRNA) and heparin. Prehybridizations were performed overnight at 68˚C in a 
hybridization solution (50% formamide, 5x SSC, 500 mg/ml yeast tRNA, 50 mg/ml 
heparin, 0.2% Tween-20, and 9.2 mM citric acid). Hybridizations were performed over 
two nights at 68˚C in a fresh hybridization solution containing antisense digoxygenin-
labeled riboprobes fractionated to ~300 nucleotides. Probes derived from 5’ and 3’ ends 
of trpm7 transcripts yielded qualitatively similar results. Larvae were then washed twice 
in 2x SSCT and three times for 2 hr each in 0.2x SSCT at 68˚C. After graded changes 
were made to maleic acid buffer (MAB; 100 mM maleic acid [pH 7.5] and 150 mM 
NaCl), larvae were blocked overnight with Roche blocking reagent in MAB at 4˚C, 
incubated over 3 nights in a fresh blocking reagent containing 1:5000 anti-digoxygenin 
alkaline phosphatase-conjugated Fab fragments (Roche), and then washed over 3 
additional nights in MAB. Larvae were then transferred to alkaline phosphate buffer (100 
mM Tris [pH 9.5], 50 mM MgCl2, 100 mM NaCl, and 0.1% Tween-20), and the color 
was developed with NBT/BCIP. 
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Cation Rescue Experiments 
 tctb508 mutant embryos and wild-type siblings were obtained from matings of 
heterozygous carriers. Chorionated embryos were reared to the 26-somite stage in water 
and then transferred to embryo medium (Westerfield 2000) (17.9 mM NaCl; “0” in 
Figure S2) or modified embryo medium (4.2 mM NaCl; “0” in Figure S2) with or without 
the addition of MgCl2 (100 mM) or CaCl2 (50 mM or 100 mM). We tested touch 
response by prodding embryos still in their chorions one time with a probe at the 
midtrunk level; any response to this stimulus was considered a rescue. Melanophore 
morphologies were examined over the head and trunk; the presence of any well-spread 
melanophores of normal size was considered a rescue. Both melanophore and touch-
response phenotypes were observed between 48 and 60 hpf. Treatments were replicated 
across multiple families two to seven times with seven to 35 embryos per condition. 
 
Quantitative Analyses of Ossification Sequence and Timing 
 We reconstructed ossification sequences in wild-type fish and trpm7 mutants by 
determining the frequency with which each skeletal element was ossified within all 
individuals of each genotype and then ordering these frequencies into ranks (Mabee, 
Olmstead et al. 2000). Elements that failed to ossify within the range of ages examined 
were ordered arbitrarily (ranks 83–87 in Figure 2.4A in the main text). Differences in 
rank between wild-type fish and mutants were highly significant between endochondral 
and intramembranous bones (Wilcoxon test: Z = 6.03, d.f. = 1, ρ < 0.0001). 
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 To assess the likelihood of bone ossification, we performed separate logistic 
regression analyses for each bone, developmental mode (endochondral and 
intramembranous), or functional-anatomical unit with genotype as a main effect and dpf 
as a covariate. Alternative models, including only genotype or including genotype and 
other main effects to control for stage and batch variability (e.g., standard length of wild-
type siblings), yielded qualitatively similar results. Note that estimates of timing 
differences between genotypes reflect only the onset of ossification as evidenced by the 
first indication of Alizarin-red staining; they do not account for differences in rate once 
ossification has started. Overall, trpm7 mutants exhibited greatly accelerated ossification 
rates for endochondral bones and correspondingly delayed ossification rates for 
intramembranous bones even after ossification had commenced. Analyses shown here 
thus underestimate the magnitude of rate differences between genotypes. Because of the 
large numbers of individual tests for logistic regression analyses, we assessed overall 
significance levels by means of a standard Bonferroni correction (α = 0.05, adjusted 
critical-significance level = 0.000127), which is likely to be overly conservative, as well 
as a more recent method of assessing false discovery rate (q value) (Storey and Tibshirani 
2003). We provide both significance thresholds in Figure 2.4B in the main text. For the 
smaller number of tests for developmental mode and functional-anatomical units, we 
provide only Bonferroni-corrected significance threshold (Figure 2.4C in the main text). 
See Table 2.S1 for a complete listing of effects and significance levels by bone. 
Statistical analyses were performed with JMP 5.0.1a for Apple Macintosh computers 




Figure 2.1. Retarded growth and altered body proportions in nutria (tct) mutant 
zebrafish with embryonic melanophore defect rescuable by divalent-cation 
supplementation. (A) Wild-type and nutria siblings, 50 dpf. (B) Higher-magnification 
image of a nutria mutant. (C) Diminished growth of nutria compared to wild-type 
siblings. Each point shows the mean standard length ± standard deviation for seven to 20 
individuals. (D–F) Embryonic melanophore defects are rescuable with supplemental 
Ca2+. (D) Wildtype embryos exhibit well-melanized and well-spread melanophores 
(arrowheads). (E) Mutants exhibit few poorly melanized and punctate melanophores or 
melanophore fragments (arrows); tct b508 is shown. (F) In a medium supplemented with 
Ca2+, mutant melanophores are more numerous, spread, and melanized (arrowheads), 
although some punctate melanophores remain (arrow). Scale bars represent the 





Figure 2.2. trpm7 expression in wild-type larvae and kidney stone formation in 
trpm7 mutants. (A-C) trpm7 expression in metamorphosing wild-type larvae. (A) At 
early stages of metamorphosis (14 dpf), trpm7 mRNA is present in mesonephric tubules 
(mt) and corpuscles of Stannius (cs). The following abbreviations are used: v, vertebral 
column; sb, swimbladder; and ct, mesonephric collecting tubule. trpm7 expression is also 
detectable in more-anterior regions of the mesonephros (not shown). (B) A higher-
magnification trpm7+ mesonephric tubule is shown. (C) Transverse section of late-
metamorphic (24 hpf) larva. trpm7 transcripts are present in mesonephric tubules and 
liver (indicated by (“li”). trpm7 transcripts are not detectable in developing endochondral 
or intramembranous bones. “my” denotes myotome and “c” denotes centrum. (D-F) 
trpm7j124e2 (nutria) mutants develop kidney stones. (D) Calcein staining reveals skeletal 
elements (na, c, ps) and ectopic mineralization (arrows). The following abbreviations are 
used: na, neural arches; c, centrum; ps, pleural spines; and nt, neural tube. (E) shows left 
most ectopic mineralization from panel (D). Epithelium (arrowheads), surrounds the 
mineralized deposit (arrow). the inset shows mineralized deposit within collecting tubule 
of another larva. (F) shows calcein staining of mineralized deposits shown in panel (E) 
and the inset. 
Scale bars represent the following: (A) μm; (B), 40μm; (C) and (D), 80μm; (E) and (F), 




Figure 2.3. trpm7 j124e2 mutants exhibit dramatic differences in skeletal development 
in comparison to wild-type. Alizarin red stains ossified bone and mineralized tissues. 
Alcian blue stains cartilage. Endochondral bone labels are red, and intramembranous 
bone labels are green. (A–H) Differences in ossification timing in the caudal complex 
between wild-type (A–D) and mutant (E–H) siblings (9–44 dpf, left to right). In mutants, 
endochodondral bones ossify earlier [panels (B) and (F): hyp. Panels (C) and (G): ep], 
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whereas intramembranous bones ossify later [panels (B) and (F): na, u, ha, c, l]. 
Compression of vertebrae and the caudal complex are evident [panels (D) and (H): 
brackets]. (I–P) The suspensorium (I–N) and branchial arches (K–P) illustrate precocious 
endochondral ossification in mutants. Advances in ossification are apparent for several 
endochondral bones at early stages [17 dpf. Panels (I) and (M): hm. Panels (K) and (O): 
ch, eh, cb1] and later stages [47 dpf. Panels (J) and (N): mpt, q, sym. Panels (L) and (P): 
bh]. (Q, U, R, V) Bones of the anterior head illustrate delayed intramembranous 
ossification in mutants. Intramembranous bones are delayed in mutants at early stages [24 
dpf. Panels (Q) and (U): pm, m, ps, ect] and later stages [44 dpf. Panels (R) and (V): f, 
en]. (S, W) Bones of the Weberian apparatus (brackets) are malformed and compressed 
in mutants. (T, X) Mineralizations within the mesonephros of mutant larvae [arrowheads 
in panel (X)]. (S) and (T) are at 35 dpf; (W) and (X) are at 30 dpf. The following 
abbreviations are used: bh, basihyal; c, centra; cb1, ceratobranchial 1; cb5, 
ceratobranchial 5; ch, ceratohyal; ect, ectopterygoid; eh, epihyal; en, entopterygoid; ep, 
epural; f, frontal; ha, hemal arches; hm, hyomandibula; hyp, hypurals; l, lepidotrichia; m, 
maxilla; mpt, metapterygoid; na, neural arches; pm, premaxilla; ps, parasphenoid; q, 
quadrate; sym, symplectic; and u, urostyle and ural 1 + 2.  





Figure 2.4. Altered sequence and timing of skeletal ossification in trpm7 j124e2 
compared to the wild-type. Wild-type larvae (n = 500) and trpm7 mutant siblings (n = 
431) were scored for ossification of 87 bones, yielding 80,997 ossification scores. 
Schematics of bone locations, functional-anatomical units, and effects for each bone are 
in the Supplemental Data. (A) In mutants, endochondral bones (red connectors) appear on 
average earlier in the ossification sequence, whereas intramembranous bones (green 
connectors) appear on average later in the ossification sequence. Bold connectors show 
bones in which ossification timing, in addition to sequence, was significantly altered 
[panel (B)]. (B) In mutants, analyses by developmental mode reveal accelerated 
ossification for many endochondral bones (red) but delayed ossification for many 
intramembranous bones (green). The x axis shows the relative likelihood of ossification 
in the wild-type compared to the mutant: estimates greater than 0 indicate that the bone is 
 41
more likely to be ossified in wild-type, and ossification is therefore delayed in the 
mutant; estimates less than 0 indicate that the bone is less likely to be ossified in wild-
type fish, and ossification is therefore accelerated in the mutant. The y axis shows 
statistical significance by chi-square value (left axis) and p value (right axis). α = 0.05 
and q = 0.01 are the thresholds of statistical significance after multiple comparisons were 
controlled for. (C) Analyses by functional-anatomical unit and developmental mode. 
Functional-anatomical units were differentially affected in the mutants even after their 
relative endochrondral and intramembranous compositions were controlled for. 
Averages: of all bones, diamond; of endochondral bones, large red point; of 
intramembranous bones, large green point. 
Error bars in (B) and (C) show one standard error for logistic regression coefficients, β. 
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Figure 2.S1. Identification of trpm7 as the gene mutated in tct (nutria) mutant 
zebrafish. (A–C) Morpholino knockdown of trpm7 phenocopies the tct embryonic 
melanophore defect. (A) In wild-type embryos, well-melanized and well-spread 
melanophores (arrowheads) cover the dorsum and head at 48 hr. (B) In tct embryos, 
melanophores are fewer, lighter, and punctuate (arrows) (Arduini and Henion 2004; 
Cornell, Yemm et al. 2004). An allele of moderate severity, tct b722, is shown. (C) Wild-
type embryos injected with a splice-blocking morpholino to trpm7 exhibit fewer, lighter, 
and punctate melanophores, as in tct. (D) Schematic of trpm7 cDNAs. Seqencing of 
trpm7 cDNAs identifies a transcript encoding at least 1773 amino acids (aa), including an 
ion transport domain (aa 873–1073) and an α kinase domain (aa 1510–1724). tct j124e1 
shows a C→A transversion resulting in substitution of a premature stop codon for 
tyrosine at aa 1545, near the start of the α kinase domain. Sequencing of tct b508 reveals a 
68 nucleotide deletion (aa 1410–1432) comprising a single exon and resulting in a 
frameshift, 16 novel amino acids, and a premature stop codon. Analyses of genomic 
DNA reveal a deletion corresponding to one exon in addition to parts of flanking introns. 
(E) Sequence electropherograms from haploid embryos that are wild-type (upper section) 
or the strong allele tct j124e1 that exhibits a premature stop codon (TAA, lower section). 
trpm7 Genbank accession number: AY860421. 
Scale bars in (A–C) represent 100 μm. 
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Figure 2.S2. Rescue of trpm7 embryonic 
defects with divalent-cation 
supplementation. Mg2+ and Ca2+ 
supplementation differentially rescued 
melanophore and touch-response phenotypes 
of tct b508 embryos. High concentrations of 
CaCl2 were toxic at normal NaCl 
concentrations (“0” in the figure), although 
embryo viability could be restored at lower 
NaCl concentrations (“-” in the figure). (A) 
Mean standard error of the mean (SEM) 
proportion of trpm7 b508 embryos exhibiting 
rescued melanophores (as in Figure 1F in the 
main text). In the standard embryo medium 
(solution A) and the reduced-NaCl rearing 
medium (B), no embryos exhibited rescued 
melanophores. In the medium with 
supplementary MgCl2 (100 mM; solutions C 
and D), many embryos exhibited partial 
melanophore rescue. Although melanophore 
rescue was not observed in the medium 
containing low supplementary CaCl2 (50 
mM) without MgCl2 (solution E), partial 
rescue occurred in media containing high 
supplementary CaCl2 (100 mM) without 
MgCl2 supplementation (solution F) or low 
CaCl2 (50 mM) with high MgCl2 (100 mM; 
solution G). (B) Mean SEM proportion of 
trpm7 b508 embryos exhibiting touch response. 
In contrast to melanophore rescue, touch response was not rescued by MgCl2 
supplementation alone (solutions C and D). Rather, touch response was maximally 
rescued with low supple-mentary CaCl2 (50 mM) without MgCl2 (solution E), although 
some rescue also occurred with higher CaCl2 (100 mM) supplementation (solution F) or 
with low CaCl2 (50 mM) in the presence of MgCl2 (100 mM; solution G). Qualitatively 
similar responses to CaCl2 and MgCl2 supplementation also were observed with trpm7 
j124e2 (nutria), which exhibit a weaker embryonic melanophore phenotype than trpm7 b508. 
The same media did not rescue similar melanophore defects of sparse (kit) or colorless 
(sox10) mutants (Parichy, Rawls et al. 1999; Dutton, Pauliny et al. 2001), demonstrating 
specificity of the effect for trpm7 (data not shown). The cellular basis of the touch 
phenotype is unclear. Because of the timing and recovery of this phenotype, it is unlikely 
to depend on hair cells of lateral-line neuromasts, recently shown to require TRP family 
members NompC and TRPA1 (Sidi, Friedrich et al. 2003; Corey, Garcia-Anoveros et al. 







Figure 2.S3. Functional-anatomical units and bone locations examined for 
ossification sequence and timing. Functional-anatomical units are color coded to match 
Figures 4A–C in the main text. (A) Units of the postcranial skeleton with bones 






Figure 2.S4. Growth retardation alone does not result in precocious ossification. 
Three siblings from a cross segregating trpm7 j124e2. (A) Wild-type fish showing 
endochondral hypurals (denoted by “hyp”) that are not yet ossified, as well as 
intramembranous vertebral centra (denoted by “c”) and fin lepidotrichia (denoted by “l”) 
that are already well ossified. (B) Even severely runted wild-type individuals that are 
from the same family and are indistinguishable in size from trpm7 mutants do not show 
precocious ossification of endochondral hypurals (or other bones); the ossification of 
intramembranous centra and lepidotrichia is delayed, reflecting an overall retardation of 
developmental rate in slow-growing fish. (C) trpm7 mutant has accelerated hypural 
ossification and delayed centra and lepidotrichial ossification compared to wild-type. In 
contrast to runted wild-type individuals, delayed ossification of intramembranous bones 
does not reflect a general developmental retardation because the absolute timing of other 
events (cartilage formation, chondrocyte and osteoblast appearance, adult pigment pattern 
formation, gut looping, swim-bladder bifurcation, etc.) does not differ dramatically from 
wild-type. 






Table 2.S1. Relative ossification timing of endochondral and intramembranous 
bones scored in trpm7j124e2 mutants and wild-type. Chi-squared and p-values of the 
likelihood of ossification of bones in wild-type relative to mutants plotted in Figure 2.4.
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Chapter 3: Molecular Regulation of Physiological Calcium and Magnesium 
Homeostasis in Zebrafish by trpm7 and stanniocalcin1 
 
Summary 
 Magnesium is vital to numerous cellular processes and the transient receptor 
potential melastatin 7 (trpm7) channel kinase is a primary regulator of cellular 
magnesium homeostasis. Here we show that trpm7 is also an important regulator of 
physiological cation homeostasis in vivo. Using zebrafish trpm7 mutants we identified 
defects in the kidney and Corpuscles of Stannius (CS), two organs that regulate 
physiological ion homeostasis. We demonstrate the presence of kidney stones in trpm7 
mutant larvae shortly after hatching, and we show their appearance is presaged by 
decreased levels of total calcium and total magnesium. Furthermore we establish a link 
between trpm7 function in the CS and stanniocalcin1 (stc1), a potent molecular regulator 
of calcium homeostasis. Using transgenic overexpression and morpholino-
oligonucleotide knockdown we demonstrate that stc1 modulates calcium and magnesium 
levels in trpm7 mutant and wild-type backgrounds. Together these analyses demonstrate 
distinct roles for trpm7 in regulating cation homeostasis through kidney function and via 
stc1 expression within the CS. 
 
Introduction 
 Calcium and magnesium are divalent cations critical for numerous biological 
processes. Calcium is an important second messenger in signal transduction pathways, 
acts as an enzymatic cofactor, maintains differences in membrane potentials, and 
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provides a crucial structural element for bone (Gomes, Leite et al. 2006; Blair, 
Schlesinger et al. 2007; Neher and Sakaba 2008; Laude and Simpson 2009). Magnesium 
is vital to the majority of cellular processes as an enzymatic cofactor, a structural 
component for proteins, RNA, and DNA, and as a modifier of receptor and channel 
activity (Grubbs and Maguire 1987; Wolf and Cittadini 1999; Alexander, Hoenderop et 
al. 2008). Whereas extensive progress has been made towards unraveling mechanisms 
underlying calcium homeostasis, relatively less is known about magnesium homeostasis 
at either cellular or organismal levels. Nevertheless, important new insights have come 
from the recent identification and analysis of two closely related genes, TRPM6 and 
TRPM7 that encode transient receptor potential (TRP) family channel kinases (Nadler, 
Hermosura et al. 2001; Runnels, Yue et al. 2001; Walder, Landau et al. 2002; Monteilh-
Zoller, Hermosura et al. 2003; Schmitz, Perraud et al. 2003; Chubanov, Schlingmann et 
al. 2007; Schlingmann, Waldegger et al. 2007; Schmitz, Deason et al. 2007). 
 Mammalian Trpm6 and Trpm7 proteins function as divalent cation channels with 
C-terminal alpha-kinase domains that regulate channel activity (Runnels, Yue et al. 2001; 
Ryazanova, Dorovkov et al. 2004; Takezawa, Schmitz et al. 2004; Demeuse, Penner et al. 
2006; Thebault, Cao et al. 2008). Trpm6 and Trpm7 are preferentially permeable to a 
number of divalent cations (Nadler, Hermosura et al. 2001; Monteilh-Zoller, Hermosura 
et al. 2003; Schmitz, Perraud et al. 2003; Voets, Nilius et al. 2004; Li, Jiang et al. 2006; 
Topala, Groenestege et al. 2007), including both magnesium and calcium. For functional 
channels to form, Trpm6 must form multimeric complexes and is generally thought to 
multimerize obligately with Trpm7 (Chubanov, Waldegger et al. 2004; Schmitz, 
Dorovkov et al. 2005). Other studies suggest homomeric Trpm6 complexes may be active 
 51
as well (Runnels, Yue et al. 2001; Monteilh-Zoller, Hermosura et al. 2003; Schmitz, 
Dorovkov et al. 2005; Li, Jiang et al. 2006; Fujiwara and Minor 2008). By contrast, 
Trpm7 can function as either a heteromeric or homomeric channel (Runnels, Yue et al. 
2001; Monteilh-Zoller, Hermosura et al. 2003; Schmitz, Dorovkov et al. 2005; Li, Jiang 
et al. 2006; Fujiwara and Minor 2008).  
 Trpm6 channels are found primarily in organs that regulate physiological ion 
levels, such as the kidney and intestines (Voets, Nilius et al. 2004; Groenestege, 
Hoenderop et al. 2006; Kunert-Keil, Bisping et al. 2006). In humans, mutations in 
TRPM6 are linked to hypomagnesemia with secondary hypocalcemia (HSH or HOMG) 
(Schlingmann, Weber et al. 2002; Walder, Landau et al. 2002), suggesting that Trpm6 
channels are primarily responsible for whole-organism magnesium homeostasis. In 
contrast to Trpm6, Trpm7 channels are expressed ubiquitously (Aarts, Iihara et al. 2003; 
Wei, Sun et al. 2007) and regulate cellular magnesium homeostasis (Nadler, Hermosura 
et al. 2001; Monteilh-Zoller, Hermosura et al. 2003; Schmitz, Perraud et al. 2003). 
Mammalian Trpm7 also functions in sensing extracellular calcium and magnesium in 
neurons (Aarts, Iihara et al. 2003; Krapivinsky, Mochida et al. 2006; Wei, Sun et al. 
2007) and in regulating cell adhesion (Clark, Langeslag et al. 2006; Su, Agapito et al. 
2006). Furthermore, the possibility exists that Trpm7 may regulate whole-organism 
cation homeostasis through its interaction with Trpm6. 
 Numerous studies have shown the importance of Trpm7 for cation homeostasis in 
vitro, yet the early lethality of Trpm7 mutations in mammalian systems has precluded 
analyses of Trpm7 roles in whole-organism cation homeostasis (Jin, Desai et al. 2008). 
By contrast, zebrafish trpm7 mutants survive into embryonic and post-embryonic stages, 
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permitting analyses of developmental and physiological functions of trpm7 in vivo 
(Elizondo, Arduini et al. 2005). Zebrafish trpm7 is detectable in all adult tissues (MRE 
and DMP, unpublished data). trpm7 is widely expressed in embryos and larvae as well, 
with particularly high transcript abundance in the tubules of the pronephric and 
mesonephric kidneys, and in the Corpuscles of Stannius (CS), a teleost-specific gland that 
regulates physiological ion homeostasis (Thisse 2004; Elizondo, Arduini et al. 2005; 
Wingert, Selleck et al. 2007). As embryos, trpm7 mutants have defects in the survival of 
melanized pigment cells, melanophores, and also develop a transient unresponsiveness to 
touch (Arduini and Henion 2004; Cornell, Yemm et al. 2004; McNeill, Paulsen et al. 
2007). As larvae, these mutants exhibit severe defects in growth and skeletogenesis while 
also developing kidney stones (Elizondo, Arduini et al. 2005). The known functions of 
mammalian Trpm7 channels suggest the pleiotropic phenotypes evident in zebrafish 
trpm7 mutants may be related to altered kidney function and cation homeostasis. The 
zebrafish trpm7 mutants therefore present a unique opportunity to study the impact of 
trpm7 activity on pronephric function and physiologic cation homeostasis. 
 Here we show that zebrafish trpm7 mutants exhibit multiple indications of 
defective cation homeostasis. We find that trpm7 mutants develop kidney stones as early 
as 5 days post-fertilization (dpf), while exhibiting reduced levels of whole-embryo total 
calcium and total magnesium by 3 and 4 dpf, respectively. We further show that the CS-
specific gene, stanniocalcin1 (stc1) is a potent downstream mediator of altered cation 
levels in trpm7 mutants. Additionally, we can demonstrate that wild-type cation levels in 
trpm7 mutants can be restored by decreasing the level of stc1. Together, our findings lay 
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the groundwork for further studies of trpm7 and its roles in cation homeostasis during 
early zebrafish development. 
 
Materials and Methods 
 
Strains and Rearing Conditions 
 Fish were reared at an average temperature of 28.5 °C except as noted below with 
a 14:10 light:dark cycle. Mutants were trpm7j124e1, trpm7j124e2, and trpm7b508, with most 
experiments using the latter allele unless otherwise noted. All mutant stocks and 
transgenic lines were maintained in the AB genetic background. 
 
Detection of Kidney Stones 
 We used a 0.5% (w/v) solution of Alizarin Red (Sigma Aldrich, St. Louis MO) 
diluted in nanopure H2O and adjusted to pH 7.5 with sodium bicarbonate. For staining, 
we incubated embryos or larvae in Petri dishes in a final concentration of 0.04% Alizarin 
Red diluted in 10% Hank’s Solution (Westerfield 2000). After overnight incubation fish 
were briefly washed in 10% Hank’s before anesthetizing with MS222 and imaging under 
epifluorescence illumination using a Texas Red filter set. To assess kidney stone 
migration, individual fish were imaged immediately following a brief rinse and then 
allowed to recover in 10% Hank’s for 12 hrs, when they were imaged for a second time. 
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Total Calcium and Magnesium Assays 
 For each sample tested, 25 embryos or larvae were pooled, anesthetized with 
MS222, rinsed briefly in nanopure H2O and collected in a 1.5 ml microcentrifuge tube. 
Fish were then dried at 65°C for 30-45 min, at which time 125 μl of 1 M HCl was added 
to each tube and acid-denatured overnight at 95°C with occasional tapping or brief 
centrifugation to collect solution at the bottom of the tube. Tubes were then centrifuged at 
maximum speed for 15 min and supernatant was collected. To assess total calcium and 
magnesium content from the supernatant, we used QuantiChrom Calcium and 
Magnesium Assays (BioAssay Systems, Hayward CA, DICA-500, DIMG-250). For 
magnesium assays, the manufacturer’s protocol was used with half-reactions and 5 μl of 
each sample tested for 2-5 dpf fish. Absorbances were read at 490 nm before and after 
addition of 10 μl of EDTA to obtain blank readings for individual wells. Statistical 
analyses were performed using JMP 8.0.1 for Macintosh (SAS Institute, Cary NC). 
 
Total RNA Isolation and cDNA Synthesis 
 For RNA preparations, 10 embryos were pooled, anesthetized in MS222 and 
homogenized in 200 μl Trizol (Invitrogen). RNA preps were performed as specified in 
the manufacturer’s protocol, resuspended in 13 μl H2O, and quantitated using a 
NanoDrop 1000 spectrophotometer (ThermoScientific). Superscript III and RNase 
Inhibitor (Invitrogen) were used in cDNA synthesis reactions primed with oligo dT 




 For quantitative PCR (qPCR), 50 μl reactions were performed in triplicate using 
0.5 μl AmplTaq (Applied BioSystems), 5 μl GeneAmp 10x PCR Buffer, 1 μl of 12.5x 
SYBR Green (Sigma-Aldrich), 1 μl of 10mM dNTPs, 2 μl of 2.5μM forward and reverse 
primer mix, and 1.5 μl diluted cDNA. For cycling, a Chromo4 real time instrument (MJ 
Research) was used with the following program: an initial denature step of 94°C for 3 m; 
followed by 40 cycles of 94°C for 20 s, 56°C for 20 s, 72°C for 20 s; and a final 
elongation step of 72°C for 5 m. To increase signal intensity, reactions were performed in 
low profile, unskirted, white 96-well PCR plates (ThermoScientific #AB-0700W). For 
each primer set, no-template control reactions were performed. Prior to qPCR, multiple 
primer sets were tested for amplification efficiency, amplification without primer-dimer 
formation, and optimal annealing temperature using gradient-PCR with annealing 
temperatures ranging from 54-62°C. Selected primers were determined to have optimal 
amplification efficiency at 56°C annealing without formation of primer-dimers. Primers 
sets (forward, reverse, 5’ to 3’) used for quantiative RT-PCR were: β-actin, 
GCATCACACCTTCTACAACGAG, AGAGTCCATCACGATACCAGTG; stc1 
(endogenous), GCAGGGCAGGAGTATTTATTAGTG, 
CAGAAAACATCTCAACCACATCCAG; stc1 (transgenic), 
TCACCTGTTCGCCAGAAACG, CCAAAAGACGGCAATATGGTGG. Primers used for 




 qPCR data was collected using Chromo4 Opticon Monitor 3 Software. For 
relative expression analysis between trpm7 mutants and wild-type siblings, data were 
analyzed using REST 2008 software (Pfaffl, Horgan et al. 2002). For absolute expression 
analysis of transgene induction following heat-shock, data were analyzed using Qgene 
software (Simon 2003). All data presented are representative of three biological 
replicates. 
 
Transgenic Expression Constructs 
 For constructing an stc1 expression cassette, we used the Tol2kit (Kwan, 
Fujimoto et al. 2007) and Multisite Gateway reagents (Invitrogen). We amplified full-
length stc1 with primers containing attB flanking sequences (Table 3.1), inserted the 
amplicon into pDONR221 and verified integrity of the open reading frame by 
sequencing. We used the pDONR-stc1 clone as the middle entry vector, combined with 
p5E-hsp70 5’ entry vector, p3E-IRES-EGFPpA 3’ entry vector, and the pDestTol2pA2 
destination vector from the Tol2kit. The resulting vector comprised an expression 
cassette with a heat shock protein hsp70 promoter controlling expression of the full 
length stc1 followed and EGFP linked by internal ribosome entry site (IRES). We co-
injected this hsp70:stc1-IRES-EGFP plasmid with Tol2 mRNA transcribed from the 
pCS2FA-transposase plasmid (Kwan, Fujimoto et al. 2007). Injected embryos were heat-
shocked at 38.5°C for 30 m at 24 hpf, then screened for mosaic expression of EGFP at 4 
h following heat-shock. GFP-positive embryos were reared to adulthood and screened for 
germline integration through their progeny. Identified germline carriers were used to 
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establish stable transgenic lines and the strongest GFP-expressing line was used for 
experiments. Similar results were observable in other transgenic lines. 
 
Heat Shock Induction 
 Two methods were used for heat-shock induction experiments. To screen 
transgenic progeny for GFP, a single heat-shock was performed by placing embryos in 
250 ml glass culture dishes (Carolina Biological), then placing dishes in a shaking water 
bath set to 38.5°C, and heat-shocking embryos for 20 m. For repeated heat-shocking over 
a period of several days, embryos were placed in clear plastic cups with mesh-covered 
holes to provide circulating water flow. Cups were then placed in a 10 gal acrylic 
aquarium with a drain and 28.5°C flowing fish system water. Temperature was controlled 
using a ProcessTech heater and temperature controller (Aquatic Ecosystems). The heater 
controller was then plugged into an electrical timer set for a cycle for 30 m on, 5.5 h off. 
 
Antisense Morpholino Oligonucleotide Injections 
 An stc1 morpholino (stc1-MO: GAAATCCGCTTTCAGGAGCATGTC) was 
designed by GeneTools LLC (Philomath, OR) to target the translational start site of the 
coding sequence. Lyophilized morpholino was resuspended in 300 μl 1x Danieau Buffer. 
The concentration was determined by diluting 2 μl in 20 μl 0.1N HCl, measuring the 
absorbance at 265 nm using a NanoDrop spectrophotometer, and calculating the 
concentration as per specifications on the GeneTools website (www.gene-tools.com). 
Morpholino was then diluted to 0.2 mM in 1x Danieau Buffer and ~0.6-0.8 nmol (~4.8-





An Early-Larval Defect in Kidney Function 
 Previous work identified kidney mineralization in late larval trpm7 mutants 
(Elizondo, Arduini et al. 2005). However, trpm7 expression within the pronephros 
(Thisse 2004; Elizondo, Arduini et al. 2005; Wingert, Selleck et al. 2007) suggests that 
trpm7 mutants could exhibit defects in embryonic or early larval defects in kidney 
function as well. To test this possibility, we examined early larvae for signs of kidney 
stone formation using the vital dye Alizarin Red (Elizondo, Arduini et al. 2005; Walker 
and Kimmel 2007). 
 Using this approach we detected kidney stones in trpm7 mutants at 5 dpf (Fig. 
3.1), but not at 2-4 dpf (data not shown). Homozygous trpm7 mutants were significantly 
more likely to exhibit kidney stones as compared to wild-type siblings (trpm7/+ and +/+; 
χ2=619, P<0.0001; Table 3.1). However, the frequency of kidney stone formation did not 
differ significantly among trpm7 mutant alleles that were lethal either at early larval 
stages (trpm7j124e1, trpm7b508) or at juvenile stages (trpm7j124e2) (χ2=0.9, P=0.6). Thus, 
defects in kidney function are neither unique to the previously studied trpm7j124e2 allele, 
nor limited to later larval stages. Moreover, the similar frequency of kidney stones across 
alleles indicates that kidney dysfunction alone is not likely to be a primary cause of 
lethality in early larval-lethal alleles. 
 To distinguish between mineralization of the epithelial tissue in the pronephric 
tubules and mineralized aggregates forming within the lumen, we tested whether kidney 
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stones moved through the kidney lumen over time. By repeated imaging of individual 
larvae, we found that kidney stones of 5 dpf mutants migrate through the pronephric 
tubules, demonstrating that kidney stones formed within the lumen and not in the 
epithelium (Fig. 3.2). These early larval requirements for trpm7 in kidney function 
suggest that disrupted cation homeostasis in trpm7 mutants begins at late embryonic or 
early-larval stages. 
 
Reduced Total Calcium and Magnesium in trpm7 Mutants 
 In humans, mutations in TRPM6 lead to hypomagnesemia because of decreased 
Mg2+ reabsorption by the kidney and intestines, which in turn disrupts calcium 
homeostasis in the parathyroid gland, resulting in hypocalcemia (Schlingmann, Weber et 
al. 2002; Walder, Landau et al. 2002). Since Trpm6 channels are thought to act in 
heteromeric complexes with Trpm7 to regulate Mg2+ homeostasis (Chubanov, Waldegger 
et al. 2004; Schmitz, Dorovkov et al. 2005) defects arising from TRPM7 mutations might 
be expected to overlap with those exhibited by TRPM6 mutants. We therefore tested if 
disruptions to cation homeostasis in zebrafish trpm7 mutants are similar to those 
associated with mammalian Trpm6 mutation. Because we could not extract sufficient 
serum from zebrafish embryos, we instead examined physiological cation levels as a 
proxy, by comparing the total magnesium and total calcium contents of wild-type and 
mutant embryos between 2–5 dpf. 
 For total calcium, mutants did not differ significantly from wild-type at 2 dpf, but 
exhibited significantly reduced levels by 3 dpf and more pronounced reductions at 4–5 
dpf (Fig. 3.3A). For total magnesium, we found reduced levels in mutants at 4 dpf and 5 
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dpf (Fig. 3.3B). While not a direct measurement of serum cation levels, the reduced total 
cation levels are consistent with hypocalcemia and hypomagnesemia in mutants. 
 
Altered Stanniocalcin-Mediated Regulation of Divalent Cation Homeostasis in trpm7 
Mutants 
 Terrestrial animals obtain calcium only from their diet and are typically 
challenged by hypocalcemic conditions. The primary regulators of calcium homeostasis, 
parathyroid hormone (PTH) and parathyroid hormone related protein (PTHrP), are, 
therefore, anti-hypocalcemic factors (Rankin, Grill et al. 1997; Akerstrom, Hellman et al. 
2005; Talmage and Mobley 2008). In contrast, fish are surrounded by an abundant 
external supply of calcium and are challenged with preventing hypercalcemia, which they 
accomplish by controlling ion influx through the gills, kidneys, and intestine. The teleost-
specific CS regulates the rates of ion influx at these sites by secreting anti-hypercalcemic 
stanniocalcins (Lafeber, Flik et al. 1988; Sundell, Bjornsson et al. 1992; Pandey 1994). 
Zebrafish stanniocalcin1 (stc1) is expressed exclusively by the CS of embryos (Thisse 
2004; Wingert, Selleck et al. 2007) (data not shown) and is antihypercalcemic (Tseng, 
Chou et al. 2009). As trpm7 is expressed particularly strongly in the CS (Thisse 2004; 
Elizondo, Arduini et al. 2005), we asked if trpm7-dependent changes in calcium might 
occur via altered stc1 regulation.  
 To test this, we assayed stc1 expression in trpm7 mutant embryos by quantitative 
RT-PCR (qPCR). We found significant increases in stc1 transcript abundance in trpm7 
mutants compared to wild-type beginning at 2 dpf and extending at least through 5 dpf 
(Fig. 3.4). The increased stc1 expression in mutants preceded the decrease in total 
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calcium (Fig. 3.3A), suggesting that upregulated stc1 and its anti-hypercalcemic activity 
may be directly responsible for reduced total calcium in trpm7 mutants. 
 
stc1 Overexpression Reduces both Total Calcium and Total Magnesium Levels 
 trpm7 mutants exhibited upregulated stc1 expression followed by decreased total 
calcium, followed, in turn, by decreased total magnesium. While decreased calcium is 
explicable by the anti-hypercalcemic activity of stc1, we hypothesized that stc1 also 
might negatively regulate magnesium levels. To test this idea in a wild-type background, 
we generated a heat shock-inducible transgenic line to overexpress stc1 (hsp70:stc1-
IRES-EGFP). Following 38.5°C heat shock for 30 m, we confirmed transgene-specific 
expression of stc1 (stc1T) by qPCR (Fig. 3.5). 
 To mimic the increased stc1 expression of trpm7 mutants in a wild-type genetic 
background, we heat-shocked transgenic and non-transgenic sibling embryos for 30 m at 
6 h intervals between 40 hpf and 120 hpf. Following heat-shock, we sorted transgenic 
embryos for the presence or absence of GFP fluorescence and performed ion assays as 
described above. We found heat-shocked, stc1T embryos exhibited reduced total calcium 
and total magnesium compared to heat-shocked, non-transgenic siblings (Fig. 3.6). This 
confirmed the anti-hypercalcemic activity of stc1 and supported the hypothesis that stc1 
influences magnesium homeostasis, either directly or indirectly. 
 The presence of increased stc1 levels in trpm7 mutants prior to kidney stone 
formation also raised the possibility that stc1 overexpression might affect kidney function 
so as to directly cause kidney stone formation. If so, heat-shocked, stc1T embryos might 
develop stones despite being wild-type for trpm7. Contrary to this expectation, however, 
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staining with Alizarin Red failed to reveal kidney stones (data not shown). This suggests 
that kidney stone formation in trpm7 mutants occurs independently of increased stc1 
activity or decreases in total cation levels. 
 
Inhibition of stc1 in trpm7 Mutants Restores Total Calcium and Total Magnesium 
Levels 
 Inhibition of zebrafish stc1 activity increased calcium levels (Tseng, Chou et al. 
2009). Additionally, our results from overexpressing stc1 in wild-type embryos suggested 
that, in trpm7 mutants, decreased total calcium and total magnesium may result from stc1 
upregulation. We therefore tested whether normal total calcium and total magnesium 
levels could be restored in a trpm7 mutant background simply by inhibiting stc1 
translation by morpholino oligonucleotide injection. 
 Embryos injected with a morpholino targeted to stc1 (stc1-MO) were 
morphologically indistinguishable from wild-type [as observed also in (Tseng, Chou et 
al. 2009)]. Moreover, trpm7 mutants injected with stc1-MO exhibited total calcium and 
total magnesium restored to levels comparable to those of uninjected wild-type siblings 
(Fig. 3.7). As expected, wild-type siblings injected with stc1-MO showed an increase in 
total calcium relative to uninjected siblings, similar to that found in (Tseng, Chou et al. 
2009). However, when comparing injected and uninjected wild-type siblings, we found 
no significant change in total magnesium (Fig. 3.7B). This result shows that stc1 
influences magnesium levels in the absence of trpm7 activity, and that wild-type trpm7 
masks this effect. These data indicate that total calcium levels are misregulated in trpm7 
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mutants due to the overexpression of stc1 and total magnesium levels can be restored in 
an stc1-dependent, but trpm7-independent, manner. 
 Given the restoration of total calcium and total magnesium in trpm7 mutants by 
stc1-MO injection, we speculated that such mutants also might fail to develop kidney 
stones. Contrary to this prediction, we did not detect a significant reduction in kidney 
stone incidence between stc1-MO injected trpm7 mutants and uninjected trpm7 mutant 
siblings at 5 dpf (Table 3.2). This outcome, along with the lack of kidney stone formation 
in heat-shocked, stc1T embryos, supports the notion that stc1 up-regulation does not 
affect kidney stone formation in trpm7 mutants. However, we cannot exclude the 
possibility of reduced efficacy of the stc1-MO at this later stage of development. 
 
Discussion 
 We show that trpm7 functions as a regulator of physiologic cation homeostasis in 
a stc1-dependent manner. Initially we identified early larval kidney stone formation in 
zebrafish trpm7 mutants at 5 dpf and demonstrated reduced total calcium and reduced 
total magnesium at 3 dpf and 4 dpf, respectively. By transgenic overexpression and 
morpholino-oligonucleotide knockdown, we also found that stc1 can modulate both 
calcium and magnesium levels in zebrafish: upregulated stc1 in a wild-type background 
decreases total calcium and total magnesium, whereas inhibition of stc1 translation 
increases these cations to wild-type levels in trpm7 mutants. Finally, we were unable to 
detect any effect of stc1 on kidney stone formation, consistent with a loss of trpm7 
activity in the kidney leading directly to to kidney stone formation in trpm7mutants. 
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 This is the first study to demonstrate an association between trpm7 and 
physiological cation homeostasis in vivo. The reduced total magnesium and total calcium 
evident in trpm7 mutants outwardly appear analogous to the hypomagnesemia and 
hypocalcemia resulting from Trpm6 defects in mammals. However, hypomagnesemia 
precedes hypocalcemia in mammalian Trpm6 mutants, whereas this sequence is reversed 
in zebrafish trpm7 mutants, in which reduced total calcium is evident at 3 dpf whereas 
reduced total magnesium is not detectable until 4 dpf. This difference between species 
highlights an important distinction between the underlying mechanisms for these defects. 
In mammalian, decreased magnesium absorption by the kidney and intestines leads to 
disruption of the calcium-sensing receptor (CaSR) in the parathyroid gland. This 
consequently disrupts regulation of calcium homeostasis and results in hypocalcemia 
(Schlingmann, Weber et al. 2002; Walder, Landau et al. 2002). In zebrafish, our data 
reveal that decreased total calcium results from misregulation of stc1 in the CS. This 
suggests a direct role for trpm7 function in the CS to regulate cation homeostasis, but also 
highlights the possibility that reduced total magnesium is secondary to reduced total 
calcium in trpm7 mutants. 
 Our identification of stc1 as a mediator downstream of trpm7 in calcium and 
magnesium homeostasis supports a model in which decreased whole-embryo cation 
levels are secondary to misregulation of stc1, and do not result directly from decreased 
trpm7 channel activity in the kidney. The mechanism by which trpm7 regulates stc1 
remains unknown. One possibility is that the kinase domain of trpm7 modulates the 
activity of CaSR within the CS. Consistent with this idea, a pharmacological activator of 
CaSR stimulates stc1 expression in salmon (Radman, McCudden et al. 2002). 
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Furthermore, CaSR is expressed within the CS, and increased stc1 levels lead to 
decreased plasma calcium and magnesium in flounder (Greenwood, Flik et al. 2009). 
These observations are concordant with our finding that increased stc1 levels in trpm7 
mutants precede decreased total calcium and total magnesium levels. 
 An intriguing result from our study was the restoration of total magnesium levels 
in trpm7 mutants following morpholino-knockdown of stc1. This trpm7-independent 
correction of total magnesium levels implies a still-unknown mechanism for magnesium 
uptake. A potential mediator of such magnesium uptake in zebrafish would be Claudin-
16. In mammals, Claudin-16 function in the Loop of Henle is critical for passive, 
paracellular divalent cation reabsorption (Kausalya, Amasheh et al. 2006), and is distinct 
from the active, transcellular transport of magnesium by Trpm6/Trpm7 complexes. In 
zebrafish, we envision that claudin-16 may be regulated by stc1 and influences the 
paracellular transport of both magnesium and calcium in trpm7 mutants. The paracellular 
mechanism for claudin-16 transport is distinct from the transcellular mechanism of 
trpm6/trpm7 channels. Consequently, stc1-regulated claudin-16 activity could function as 
a trpm7-independent compensatory mechanism. While a zebrafish orthologue of Claudin-
16 has not been identified, the presence of such genes in other fishes (Kollmar, Nakamura 
et al. 2001; Loh, Christoffels et al. 2004) suggests one may yet be found. 
 Our study also provides new insights into the development and physiological 
bases of kidney stone formation in trpm7 mutants. We found that restoration of total 
calcium and total magnesium was insufficient to rescue the kidney stone phenotype. This 
outcome and the strong expression of trpm7 in the kidney itself, suggest a direct 
requirement for trpm7 activity in kidney function. Our finding that inhibition of stc1 
expression failed to repress kidney stone formation also supports this inference, though 
we cannot exclude the possibility of reduced morpholino efficacy at 5 dpf (Nasevicius 
and Ekker 2000). We speculate that kidney stone formation in the pronephric tubules may 
result from a localized decrease in the reabsorption of magnesium, owing to reduced 
trpm6/trpm7 channel activity, leading to increased precipitation of magnesium or calcium 
phosphate. 
 Finally, though we have characterized the early-larval effects of increased stc1 on 
cation homeostasis in trpm7 mutants, it is also possible that stc1 is an effector of later 
stage defects in growth and bone development in these mutants (Elizondo, Arduini et al. 
2005). Studies of mammalian stanniocalcins have linked increased expression to 
disrupted bone development and growth defects (Filvaroff, Guillet et al. 2002; Varghese, 
Gagliardi et al. 2002; Gagliardi, Kuo et al. 2005; Wu, Yoshiko et al. 2006; Chang, Hook 
et al. 2008) similar to those found in trpm7 mutants at later larval stages. The inducible 
stc1 transgenic zebrafish we have generated for over-expressing stc1 should be useful for 





Figure 3.1. Kidney stone formation in early larval trpm7 mutants. Brightfield (A) and 
fluorescent (B) views of Alizarin Red-stained kidney stone in the pronephric tubule of a 5 
dpf trpm7 mutant. Dashed lines indicate the dorsal and ventral margins of the pronephric 
tubule. Arrow indicates Alizarin Red-stained kidney stone visible in both brightfield and 
fluorescent views. Solid vertical lines indicate reflective pigment cells (iridophores) that 
are evident in epifluorescent illumination using both the mCherry filter set (shown) and 






Figure 3.2. Migration of kidney stones in trpm7 mutants. Alizarin Red-stained trpm7 
mutant kidney stones imaged (A) immediately post-staining and (B) 12 h post-staining. 
Dotted line indicates pronephric tubule. Arrowheads indicate Alizarin Red-stained kidney 
stones. The fragmentation and movement of the posterior stone in (A) can be viewed in 





Figure 3.3. Total calcium and magnesium concentrations in trpm7 mutants. Calcium 
(A) and magnesium (B) levels are shown as least squares means ± SE after controlling 
for batch-specific variation (n = 120 mutant and wild-type samples at stages 2–5 dpf). 
Overall analyses of variance: calcium, F7,112 = 467, P<0.0001; magnesium, F7,112 = 
33.8, P<0.0001. Samples with the same letters are not significantly different by Tukey-





Figure 3.4. Expression of stc1 in trpm7 mutants as compared to wild-type by qPCR. 
stc1 mRNA is more abundant in trpm7 mutants at each stage examined. Values were 
normalized to β-actin and scaled relative to wild-type sibling levels of stc1. Error bars 





Figure 3.5. Induction of transgenic stc1 with and without heat-shock (HS) assayed 
by qPCR. Induction of the transgene is observed in GFP+ embryos 60 min following 
heat shock of 5 dpf larvae. Absolute expression levels were scaled to β-actin expression. 
Endogenous stc1 levels were assayed with primers targeting the 3’ UTR while transgenic 
stc1 were assayed with primers targeting the 3’ coding sequence and the IRES sequence 
of the transgene. Transgene levels in GFP- larvae and larvae without HS are comparable 





Figure 3.6. Total calcium and magnesium levels in transgenic stc1 larvae. Reduced 
total calcium (A) and total magnesium (B) levels in heat-shocked transgenic (GFP+) 
larvae compared to heat-shocked non-transgenic (GFP-) larvae. Calcium and magnesium 
levels represent least squared means + SE after controlling for variation among batches (n 
= 16 mutant and wild-type samples at 5 dpf). Overall analyses of variance: calcium, 
F1,14 = 499, Ρ<0.0001; magnesium, F1,14 = 313, Ρ<0.0001. Samples with the same 





Figure 3.7. Restored cation levels in stc1 morpholino-injected larvae. trpm7 mutant 
larvae injected with stc1-MO exhibit calcium (A) and magnesium (B) levels restored to 
wild-type levels. Furthermore, wild-type embryos injected with the stc1-MO exhibit 
significantly increased total calcium (A) as compared with uninjected wild-type siblings, 
though total magnesium (B) of injected and uninjected wild-type embryos did not differ 
significantly. Overall analyses of variance: calcium, F3,28 = 29.2, Ρ<0.0001; magnesium, 
F3,28 = 14.2; Ρ<0.0001. Sample groups with the same letters are not significantly 
different from each other using a Tukey-Kramer HSD Test; α=0.050. 
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TABLE 3.1.  Incidence of kidney stone formation in trpm7 mutant alleles 
and wild type siblings at 6 dpf. 
 Total KS+ KS- %KS+ Likelihooda
wt sibling 183 1 182 0.5% 
trpm7-j124e1 60 56 4 93.3% 
222.937 
wt sibling 146 2 144 1.4% 
trpm7-j124e2 50 47 3 94.0% 
177.693 
wt sibling 177 0 177 0.0% 
trpm7-b508 57 53 4 93.0% 
221.417 
a χ-squared analysis, all Ρ <0.0001* 
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 TABLE 3.2.  Incidence of kidney stone formation in stc1-MO injected 
trpm7 mutants and wild-type siblings. 
 Total KS + KS - 
 
 
 %KS +  




trpm7-b508 41 38 3 92.7% 
uninjected 




trpm7-b508 34 32 2 94.1% 
stc1-MO 
χ-squared analysis 











 I have also conducted a number of other experiments that, while somewhat 
informative towards a broader understanding of zebrafish trpm7 function, are 
nevertheless incomplete on their own. Briefly I describe work towards establishing 
zebrafish lines with conditional trpm7 function, both through the identification of 
temperature sensitive (TS) mutant alleles and establishment of a transgenic line capable 
of inducible overexpression of a dominant-negative form of trpm7 (DN-trpm7). 
Additionally, I discuss experiments conducted to determine distinctions in water 
composition between fish facilities in Austin and Seattle, and how they impact 
observable phenotypes. These experiments lay the groundwork for future avenues of 




Appendix I: Conditional trpm7 Activity 
 
 As essential to understanding what factors govern developmental changes is 
determining when these factors are required. Though we have linked trpm7 to growth, 
bone development, and kidney function, we know little about the temporal requirements 
these developmental processes have for trpm7 function. In trpm7 mutants, while growth 
and bone defects do not manifest until approximately 14dpf, embryonic melanophore 
defects and touch insensitivity coupled with early larval kidney stone formation illustrate 
early requirements for trpm7 function. The distinction between embryonic and larval 
defects in mutants suggests that distinct temporal requirements for trpm7 function exist. 
Accordingly, a temporal analysis of trpm7 activity may distinguish between early and 
late requirements for trpm7 in growth, bone development and kidney function. To test 
these hypotheses we therefore set out to identify and establish conditional trpm7 mutant 
alleles and create an inducible transgenic line capable of overexpressing a dominant-
negative trpm7 (DN-trpm7). In addition to allowing us to study temporal requirements 
for trpm7 function, this approach may also potentially provide inducible models for 
studying cation homeostasis, kidney stone formation and bone development. 
 
Identification and Characterization of Temperature Sensitive trpm7 Mutant Alleles 
 In zebrafish, studies with temperature sensitive (TS) alleles have shown: that kit, a 
receptor tyrosine kinase, has distinct temporal roles promoting cell migration and cell 
survival (Rawls and Johnson 2001); that the specific stage of floor plate induction occurs 
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during gastrulation (Tian, Yam et al. 2003); that reg6 promotes early but not late 
vascularization in regenerating fins (Huang, Lawson et al. 2003); and that reg6 is just one 
of many TS alleles identified in a mutant screen for genes affecting fin regeneration 
(Johnson and Weston 1995). Furthermore TS studies in our lab have allowed 
identification of a critical period during pigment pattern metamorphosis requiring puma 
function (Parichy, Turner et al. 2003) and identification of an ongoing requirement for 
fms activity in maintaining a xanthophore cell-lineage and organizing melanophore 
stripes (Parichy and Turner 2003). Therefore, TS studies in zebrafish are a proven and 
powerful approach to assess temporal requirements over a broad range of developmental 
defects. To identify TS trpm7 mutant alleles in zebrafish we made use of its 
thermoplasticity and the ability to obtain large numbers of embryos to perform a non-
complementation screen using 24°C and 34°C as permissive and restrictive temperatures. 
 
Non-Complementation Screening 
 Non-complementation screens are routinely used in zebrafish to identify new 
alleles of established mutant lines. Briefly, zebrafish males mutagenized with ENU have 
large numbers of recessive, germline mutations. When these males are crossed to wild-
type zebrafish, the individual progeny will each be heterozygous carriers for a number of 
different mutations. The ability to obtain ~200-400 embryos per clutch allows the 
production of large numbers of carriers of unique recessive mutations. The majority of 
these fish are viable and have no observable phenotype. However, if the mutagenized 
males are crossed into a mutant background, identification of new mutant alleles can be 
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observed at a low frequency (~1/1000 embryos) through non-complementation of 
different recessive alleles of the same gene. If the desired mutant phenotype is observable 
in embryos, large numbers of embryos can be screened in just a few days, and a number 
of new alleles can be identified within a few weeks. Furthermore, if these embryos are 
initially reared at a restrictive temperature (34ºC) and a mutant phenotype is observed, 
the mutant embryo can then be downshifted to permissive temperature (24ºC) to select 
for TS alleles. 
 trpm7 mutants display an embryonic melanophore deficiency easily observable at 
2dpf. This allows for the rapid identification of new trpm7 mutant alleles in embryos 
reared at restrictive temperature. Subsequently, these mutants can be downshifted to 
permissive temperature to screen for temperature sensitivity. If the new mutant allele is 
temperature-sensitive, then rearing at permissive temperature will restore trpm7 gene 
function and prevent onset of the later-stage phenotypes. Consequently, a viable mutant 
can be obtained. trpm7 has a very large coding sequence (~5.3kb), which means there is a 
higher probability of identifying mutations causing amino acid changes in the coding 
sequence. Therefore the likelihood that viable TS alleles will be identified is extremely 
high. 
 In the non-complementation screen for TS trpm7 alleles I screened ~81,500 
embryos and identified 167 putative new alleles based on melanophore defects, yielding 
an allelic frequency of 1 mutant allele for every ~488 embryos screened. Of these 167 
putative alleles, I recovered 12 founders that grew to adulthood and were sexually fertile 
and I was able to establish stocks for 9 new alleles. 
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Characterization of TS alleles 
 Of the 9 new alleles with established stocks, 5 displayed some measure of 
temperature sensitivity and variable phenotypic severity with respect to the characteristic 
embryonic melanophore defect of trpm7 mutants (Table A.1) and can be compared to 
previously described non-TS alleles (Table A.2). Of the newly identified TS alleles, the 
nutria-110 and nutria-48 alleles show the most promise with their combination of 
temperature sensitivity and moderate severity of melanophore defect (Figure A.1). 
Furthermore, increased severity of melanophore defects is observed with these alleles 
when placed in combination with the original nutria allele (data not shown). 
 When assessed for growth defects, 3 non-TS alleles showed minor growth 
retardation, but developed into fertile adults. Furthermore, only 1 TS allele, trpm7n110 
exhibited any defect in growth, with a minor growth retardation observable when reared 
at restrictive temperature (Figure A.2). This defect was also only seen when the TS 
nutria-110 allele was crossed with the non-TS trpm7j124e2 allele and showed variable 
penetrance. As will be discussed in Appendix II, it is possible that water composition and 
mineral ion content may influence penetrance of later stage phenotypes; increased 
severity of TS alleles may be obtainable with different water compositions. 
 
Construction of an Inducible Transgenic Dominant-Negative trpm7 Line 
 As an alternative and complimentary approach to TS alleles, I developed a 
transgenic zebrafish line containing a dominant-negative form of zebrafish trpm7 under 
the control of the inducible heat-shock protein 70 (HSP70) promoter and with an IRES-
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EGFP expression cassette following the DN-trpm7 coding sequence. Using this approach, 
heat-shock induction of the transgene can inhibit trpm7 activity in a controllable manner 
and allow for independent testing of temporal requirements for trpm7 activity. 
 
Construction of a Dominant-Negative Zebrafish trpm7 Gene 
 In research with mammalian trpm7, site-directed mutagenesis targeting the coding 
sequence for a highly conserved region of the channel pore domain yielded a gene with a 
dominant-negative effect on trpm7 channel activity (Krapivinsky, Mochida et al. 2006). I 
identified this amino acid sequence as being entirely conserved between mammalian 
forms of TRPM7 and zebrafish trpm7 (Figure A.3a). I therefore performed site-directed 
mutagenesis on a full-length zebrafish trpm7 clone to induce the same amino acid 
changes as those found in the mammalian DN. After confirming changes by sequencing 
(Figure A.3b), I used the Tol2 gateway toolkit (Kwan, Fujimoto et al. 2007) to construct 
an expression vector composed of an HSP70 promoter, the DN-trpm7 coding sequence 
and an IRES-EGFP cassette. 
 
Establishing and Validating a Transgenic DN-trpm7 Zebrafish Line 
 After constructing the DN-trpm7 vector, I co-injected the DNA vector with Tol2 
mRNA to induce a high degree of incorporation of the expression vector into the genomic 
DNA. Using this approach I was able to obtain a large number of embryos with mosaic 
integration of the transgene, and test the efficacy of the DN-trpm7 in recapitulating trpm7 
mutant embryonic phenotypes (Figure A.4a). Embryos at 24 hpf were heat-shocked twice 
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for 1hr each time, with 3hrs between heat-shocks. After growing injected embryos to 
adulthood, progeny were screened for the transgene through presence or absence of GFP 
expression following heat-shock to identify germline carriers. Two germline stocks were 
established with melanophore (Figure A.4b) and touch unresponsiveness defects 
following a cycling heat shock at 38.5°C from 20-44hpf, with 30min HS followed by 
5.5hrs recovery. Of note is the fact that a single heat-shock was insufficient to obtain any 
melanophore defects, and only after multiple heat shocks is a phenotype observable. This 




Appendix II: The Effects of Water Composition on trpm7 Mutant Phenotypes 
 
 Trpm7 is a divalent cation channel and previous work has shown that high levels 
of magnesium and calcium in the water can reduce the expressivity of the trpm7 
embryonic mutant phenotypes (Elizondo, Arduini et al. 2005). Similar experiments with 
high levels of magnesium and calcium proved to be toxic at larval stages. However, when 
rearing trpm7j124e2 (nutria) mutants in different fish facilities at the University of Texas 
and the University of Washington, I observed differing expressivity of larval mutant 
phenotypes, with lesser bone mineralization defects in fish reared at UW. Additionally, 
characterization of the trpm7b722 (dalmation) mutant allele (Cornell, Yemm et al. 2004) 
also reveals distinctions between severity of growth defects. When reared at the 
University of Iowa, these mutants exhibit the severe growth defect characteristic of the 
trpm7j124e2 mutant background, however, the trpm7b722 mutants at UT and UW display 
little to no growth defects. This phenotypic plasticity across fish facilities suggested the 
ion content of the different water compositions between the facilities may influence 
trpm7 mutant larval phenotypes. 
 I therefore had the fish water of the facilities at UT, UI, and UW analyzed by 
AmTest Laboratories for mineral content to determine whether there were changes that 
were consistent with differences in phenotype severity (Table A.3). I ranked the fish 
facilities with respect to the phenotypic severity of bone or growth defects in the nutria 
and dalmation alleles (Figure A.5). Taking into account the varied expressivity of growth 
defects for dalmation mutants and bone defects for nutria mutants, we ranked UI water as 
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most severe followed by UT with medium severity and UW with low severity. Using this 
ranking we find that while distinctions existed between sodium levels and potassium 
levels, only the changes in levels of calcium and magnesium correlate with the range of 
phenotypic severity. Specifically we find both decreasing levels of calcium and 
increasing levels of magnesium associated with decreasing phenotypic severity. 
 The changes in calcium and magnesium levels between the fish facilities occur 
over a very narrow range of 8.5mg/L to 27mg/L for magnesium and 8.2mg/L to 18mg/L 
for calcium. This equates to a range of 3.5mM to 11mM for magnesium and 2.5mM to 
4mM for calcium, which contrasts with the 100mM and 50mM concentrations for 
magnesium and calcium used in previous rescue experiments. Therefore it is possible that 
a narrow range of magnesium and calcium concentrations may influence phenotypic 
plasticity for trpm7 mutants at larval stages. 
 As a test for this, we reconstituted a UT-like water composition with 10mg/L 
[Ca2+] and 20mg/L [Mg2+] to rear nutria mutants at UW, using a 1% Hank’s solution 
(Westerfield 2000) as a foundation, then adding appropriate amounts of MgSO4 and 
CaCl2. Using this approach we are able to detect bone defects in nutria mutants. 
 While able to reconstitute the bone defects in trpm7 mutants by altering the levels 
of calcium and magnesium in the rearing media, it remains uncertain whether one or both 
of the cation levels is crucial to proper bone development. Similar experiments varying 
the concentrations of the cations between 10mg/L to 50mg/L proved inconclusive, and it 
remains possible that there are distinct requirements for these cations in survival, growth, 
and bone development. For example, decreased calcium levels may reduce the premature 
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mineralization of bone in mutants, but also may exacerbate hypocalcemia and negatively 
affect survival. In contrast, while increased magnesium might alleviate hypomagnesemia 
in mutants and rescue growth defects, it also may exacerbate kidney stone formation and 
bone defects. There is likely to be a delicate balance between cation levels and distinct 
effects on growth, bone development and survival in mutants. 
 Furthermore, other recent findings, (personal communication A. Fleig), suggest 
that other ions, such as potassium and sodium also may influence trpm7 channel activity. 
As will be discussed in the next section, phosphate levels may also be altered in trpm7 
mutants. Therefore dissecting which cation influences what phenotype may prove more 
complex than simple changes in calcium or magnesium, but the recent identification of 
decreased calcium and magnesium levels in early larval mutants should facilitate the 
design of future experiments. 
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Appendix III: Kidney Stone Formation in Heterozygous trpm7 larvae 
 
 In Chapter 3 I demonstrated kidney stone formation in homozygous trpm7 
mutants as early as 5dpf. At this stage, mutants manifesting kidney stones are detectable 
with extended incubation with the vital dye alizarin red. Additionally, when using 
extended incubation with a similar vital dye, calcein, on aSB:6.1SSL stage larval trpm7 
mutants and siblings, I am able to identify kidney stones in mutants as expected (Figure 
A.6). However, in some instances when reared in Texas-like water, a subset of wild-type 
siblings also develop kidney stones (Figure A.6). Genotyping with the tightly linked 
microsatellite marker, z53176, indicates that 5/5 wild-type siblings manifesting kidney 
stones are heterozygous for the trpm7 mutant allele while 3/5 wild-type siblings without 
kidney stones were also heterozygous. This suggests that trpm7 mutant carriers have an 
increased susceptibility to late onset kidney stone formation and indicates that there may 
be decreased channel activity with in heterozygotes. Future analyses of larval fish 
heterozygous for the trpm7 mutant allele may reveal other, more subtle defects. 
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Appendix IV: Potential Changes in Phosphate Levels in trpm7 Mutants 
 
 In Chapter 3 I discussed the identification of increased levels of stc1 in trpm7 
mutants. stc1 is a primary regulator of calcium homeostasis through anti-hypercalcemic 
activity, however it is also known to regulate phosphate levels through anti-
hypophosphatemic activity. In an attempt to ascertain whether there were also changes in 
the regulation of phosphate in trpm7 mutants I attempted to evaluate phosphate levels in 
trpm7 mutants and to characterize potential changes in an important regulator of 
phosphate homeostasis, fibroblast growth factor-23 (fgf23). 
 Using the same samples of total ion preps used to assay calcium and magnesium, 
I also attempted to evaluate total phosphate levels in trpm7 mutants with the 
QuantiChrom Phosphate Assay Kit (Bioassay Systems DIPI-500). I determined that to 
reach the assay’s linear detection range, I needed to dilute samples 1:50. However, in this 
range there was a high degree of sample to sample variation between replicates, and 
unlike with magnesium and calcium assays, no individual well blank values could be 
ascertained through chelation with addition of EDTA. Therefore, I was unable to 
determine whether any changes in phosphate levels exist for trpm7 mutants. 
 An anti-hyperphosphatemic factor (Shimada, Hasegawa et al. 2004), fgf23 
controls uptake of phosphate through regulation of sodium-phosphate transporters in the 
kidney (Marsell, Krajisnik et al. 2008), is a known molecular marker for kidney stone 
formation (Rendina, Mossetti et al. 2006), and may influence bone mineralization 
(Larsson, Marsell et al. 2004). It therefore represents a prime candidate as a molecular 
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mediator of potential changes in phosphate regulation in trpm7 mutants. When examining 
fgf23 expression in trpm7 mutants by in situ hybridization, I find expression specifically 
in the CS, and there appears to be a gross increase of expression in trpm7 mutants when 
compared to wild-type siblings or mitfa mutants (Figure A.7), (which lack melanophores 
obscuring expression in the CS). When examined by quantitative PCR, increased fgf23 is 
also detectable in mutants at 48hpf (Figure A.7). One possible explanation for this 
increase is a compensatory response to the anti-hypophosphatemic activity of increased 
stc1 levels. Additionally, increased fgf23 may influence bone defects or kidney stone 
formation in trpm7 mutants. Therefore I developed an inducible transgenic line for fgf23 
expression following the same approach used for stc1 discussed in Chapter 3. 
 I hypothesized that increased fgf23 expression may lead to kidney stone formation 
in trpm7 mutants, however no kidney stones were detectable by Alizarin Red staining in 
wild-type HS:fgf23 fish following a 4x/day 30 minute heat shock cycle from 2dpf-5dpf. 
Furthermore, examination of fgf23 expression in 3-5dpf trpm7 mutants from multiple 
biological replicates showed variable changes in levels of fgf23 (Figure A.7). With an 
increase in fgf23 expression only verifiable at 48hpf and no discernable kidney stone 
formation after induction of fgf23 expression, it remains inconclusive what role fgf23 has 
in trpm7 mutants. 
 While a detectable difference in fgf23 expression is present in 48hpf trpm7 
mutants, it is possible that it is only a transient secondary response to increased stc1 
expression and has no lasting effect on trpm7 mutant phenotypes or phosphate levels. To 
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better assess these phosphate levels in trpm7 mutants it appears that alternative 
approaches are necessary, possibly through the use of radioactive P32 uptake assays. 
Interestingly, the localized expression of fgf23 in the CS does however suggest the 
corpuscles may have a larger role in regulating ion homeostasis than previously 
considered, and it may be worthwhile to examine whether other regulatory factors exhibit 
localized expression in this domain. Finally, the transgenic HS:fgf23 line should also 
facilitate any future studies of phosphate metabolism or fgf23 function in zebrafish. 
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Appendix V: Other Potential Effects of stc1 Overexpression 
 
 While I characterized the early larval defects associated with transgenic stc1 
overexpression, other phenotypes were observable at later stages in heat-shocked fish. 
These phenotypes were present only in fish carrying multiple copies of the transgene and 
likely are a result of higher levels of overexpression. 
 In addition to the known anti-hypercalcemic effects of stanniocalcins in fish 
(Lafeber, Flik et al. 1988; Sundell, Bjornsson et al. 1992; Filvaroff, Guillet et al. 2002; 
Varghese, Gagliardi et al. 2002), mammalian studies have also shown that overexpressing 
stanniocalcin leads to growth defects (Filvaroff, Guillet et al. 2002; Varghese, Gagliardi 
et al. 2002). The possibility therefore exists that the increased stc1 expression in trpm7 
mutants contributes to growth defects in these mutants. When rearing transgenic fish 
carrying multiple copies of the stc1 transgene following heat shock at early embryonic 
stages, (24-48hpf), I identified a growth defect that begins to manifest at larval stages 
(Figure A.8). 
 Interestingly, this growth defect persists in larval stages even if no further heat-
shock cycles are administered during larval stages. A possible explanation for this would 
be an early overload of transgenic stc1 production results in an irreversible shutdown of 
endogenous stc1 production. It remains to be determined whether this growth defect is 
analogous to growth defects observed in mammalian systems following stc 
overexpression, or whether this growth defect is similar to that observed in trpm7 
mutants. Finally, cursory observation also suggests an increase in larval melanophore size 
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or number in these heat-shocked individuals (Figure A.8). This may reflect a 
responsiveness of melanophores to calcium levels in these transgenic individuals and be 
related to an established link between detection of extracellular calcium levels and 





Figure A.1. A non-complementation screen for temperature-sensitive trpm7 mutant 
alleles. The severity of the trpm7 mutant melanophore defect at 2 dpf can be viewed for 
TS alleles nutria-48 (A) and nutria-110 (B) when reared at a restrictive temperature of 






Table A.1. Summary of alleles recovered from the non-complementation screen and 
their phenotypes.  Table lists strength of temperature sensitivity, melanophore and 
growth defects for new trpm7 alleles. nutria-48, -110, -154, -156 exhibit temperature 
sensitivity in the range of 24˚C-34˚C with respect to the melanophore defect, while 
nutria-19, -26, -41, -155 are weak alleles with no temperature sensitivity. nutria-127 
exhibits marginal temperature sensitivity with a slightly permissive temperature of 24˚C, 




Table A.2. Summary of independently isolated trpm7 mutant alleles. Table 
summarizes nomenclature and observed phenotypic severity for previously described 






Figure A.2. Temperature sensitive growth defect with nutria-110 TS allele.  nutria-
110 / nutria mutants and wild-type siblings reared at (A) permissive temperature (24˚C) 
and (B) restrictive temperature (34˚C).  A growth defect is evident at restrictive 







Figure A.3. Construction of a zebrafish DN-trpm7.  Three amino acids in the channel 
pore domain of the trpm7 protein highly conserved between mammals and fish were 
targeted for site directed mutagenesis (A). Sequencing confirms site-directed changes in 







Figure A.4. Mosaic and germline melanophore defects following heat-shock of 
transgenic DN-trpm7 embryos.  Embryos injected with the Hsp70::DN-trpm7 construct 
exhibit a mosaic melanophore defect following heat-shock (B,D) when compared with 
injected, non heat-shocked embryos (A,C). The severe melanophore defect in F1 progeny 
of a germline carrier for Hsp70::DN-trpm7 construct following heat-shock (E) is 







Table A.3. Water mineral composition of different fish facilities. Table summarizes 
ion content of water from fish facilities at the University of Washington, Iowa, and 
Texas. Values are listed as mg/L. Notable differences in levels are observable in calcium, 





Figure A.5. Association of magnesium and calcium content with trpm7 phenotypic 
severity. In water which manifests more severe trpm7 mutant defects increasing calcium 







Figure A.6. Kidney stone formation in mutant and heterozygous trpm7 larvae. After 
extended staining with calcein, kidney stones are observable in trpm7 mutant and 







Figure A.7. fgf23 expression by in situ hybridization and qPCR. In situ hybridization 
reveals strong fgf23 expression in the CS in trpm7 mutants (A), while mitfa mutants, 
(which lack melanophores but are otherwise wild-type), have no expression over the 
same exposure time (B). qPCR shows upregulation of fgf23 in trpm7 mutants at 2 dpf, 
however at other stages results are inconclusive as different biologic replicates show 







Figure A.8. Later stage phenotypes with transgenic Hsp70::stc1 overexpression.  
Early overexpression, beginning at ~24 hpf, of stc1 in homozygous transgenic fish leads 
a growth defect (A). Additionally, superficial observations suggest an increase in 
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